| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | NCOA2 SUPT20HL1 ARID1B NKX2-1 SS18L1 KAT6A NCOA1 SUPT20HL2 CITED1 ZMIZ1 RAD54L2 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 6.40e-10 | 562 | 80 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | transcription coactivator activity | NCOA2 ARID1B NKX2-1 SS18L1 KAT6A NCOA1 CITED1 ZMIZ1 ARID1A CREBBP EP300 NOTCH1 | 2.88e-09 | 303 | 80 | 12 | GO:0003713 |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | NCOA2 FOXL2 MECR NKX2-1 KAT6A AHR NCOA1 ARID1A TAF1L CREBBP JMJD1C EP300 TBP PASD1 | 7.02e-08 | 582 | 80 | 14 | GO:0140297 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | NCOA2 FOXL2 MECR NKX2-1 AHR NCOA1 ARID1A TAF1L CREBBP JMJD1C EP300 TBP | 9.83e-08 | 417 | 80 | 12 | GO:0061629 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NCOA2 SUPT20HL1 SYNPO2 ARID1B NKX2-1 ABI2 SS18L1 KAT6A NCOA1 SUPT20HL2 CITED1 ZMIZ1 RAD54L2 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 5.69e-07 | 1160 | 80 | 18 | GO:0030674 |
| GeneOntologyMolecularFunction | nuclear receptor binding | 8.30e-07 | 187 | 80 | 8 | GO:0016922 | |
| GeneOntologyMolecularFunction | chromatin binding | NCOA2 ARID1B GLI2 KAT6A NCOA1 CHD8 CITED1 CHD7 ARID1A TAF1L CREBBP JMJD1C EP300 NOTCH1 | 1.25e-06 | 739 | 80 | 14 | GO:0003682 |
| GeneOntologyMolecularFunction | transcription factor binding | NCOA2 FOXL2 MECR NKX2-1 KAT6A AHR NCOA1 ARID1A TAF1L CREBBP JMJD1C EP300 TBP PASD1 | 1.56e-06 | 753 | 80 | 14 | GO:0008134 |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.85e-06 | 51 | 80 | 5 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.70e-06 | 55 | 80 | 5 | GO:0061733 | |
| GeneOntologyMolecularFunction | RNA polymerase II general transcription initiation factor binding | 3.91e-06 | 27 | 80 | 4 | GO:0001091 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 4.18e-06 | 60 | 80 | 5 | GO:0034212 | |
| GeneOntologyMolecularFunction | aryl hydrocarbon receptor binding | 5.11e-06 | 9 | 80 | 3 | GO:0017162 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | NCOA2 SUPT20HL1 SYNPO2 ARID1B NKX2-1 ABI2 SS18L1 KAT6A NCOA1 SUPT20HL2 CITED1 ZMIZ1 RAD54L2 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 5.26e-06 | 1356 | 80 | 18 | GO:0060090 |
| GeneOntologyMolecularFunction | general transcription initiation factor binding | 5.76e-06 | 64 | 80 | 5 | GO:0140296 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 1.43e-05 | 37 | 80 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.53e-05 | 78 | 80 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | peptide lactyltransferase (CoA-dependent) activity | 1.59e-05 | 2 | 80 | 2 | GO:0120300 | |
| GeneOntologyMolecularFunction | histone H3K27 acetyltransferase activity | 1.59e-05 | 2 | 80 | 2 | GO:0044017 | |
| GeneOntologyMolecularFunction | SMAD binding | 2.46e-05 | 86 | 80 | 5 | GO:0046332 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 2.72e-05 | 15 | 80 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | histone modifying activity | 3.72e-05 | 229 | 80 | 7 | GO:0140993 | |
| GeneOntologyMolecularFunction | histone H3K18 acetyltransferase activity | 4.74e-05 | 3 | 80 | 2 | GO:0043993 | |
| GeneOntologyMolecularFunction | N-acyltransferase activity | 5.59e-05 | 102 | 80 | 5 | GO:0016410 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 6.13e-05 | 104 | 80 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.43e-04 | 66 | 80 | 4 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.43e-04 | 66 | 80 | 4 | GO:0001098 | |
| GeneOntologyMolecularFunction | TFIIB-class transcription factor binding | 2.35e-04 | 6 | 80 | 2 | GO:0001093 | |
| GeneOntologyMolecularFunction | p53 binding | 2.59e-04 | 77 | 80 | 4 | GO:0002039 | |
| GeneOntologyMolecularFunction | TBP-class protein binding | 3.10e-04 | 33 | 80 | 3 | GO:0017025 | |
| GeneOntologyMolecularFunction | promoter-specific chromatin binding | 3.45e-04 | 83 | 80 | 4 | GO:1990841 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 5.59e-04 | 167 | 80 | 5 | GO:0031490 | |
| GeneOntologyMolecularFunction | protein domain specific binding | NCOA2 RAP2B ZFYVE9 ATXN2 ABI2 SIGLEC10 CHD8 CITED1 RRM1 DNAJC6 CREBBP | 7.09e-04 | 875 | 80 | 11 | GO:0019904 |
| GeneOntologyMolecularFunction | nuclear estrogen receptor binding | 1.26e-03 | 53 | 80 | 3 | GO:0030331 | |
| GeneOntologyMolecularFunction | transcription coactivator binding | 1.33e-03 | 54 | 80 | 3 | GO:0001223 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 1.40e-03 | 55 | 80 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.70e-03 | 127 | 80 | 4 | GO:0008094 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TBX22 NCOA2 FOXL2 NKX2-1 GLI2 AHR NCOA1 CHD7 TAF1L CREBBP SOX13 EP300 TBP PASD1 | 1.83e-03 | 1459 | 80 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.89e-03 | 61 | 80 | 3 | GO:0030374 | |
| GeneOntologyMolecularFunction | intronic transcription regulatory region sequence-specific DNA binding | 2.07e-03 | 17 | 80 | 2 | GO:0001161 | |
| GeneOntologyMolecularFunction | transcription coregulator binding | 2.42e-03 | 140 | 80 | 4 | GO:0001221 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.68e-03 | 238 | 80 | 5 | GO:0016747 | |
| GeneOntologyMolecularFunction | nuclear glucocorticoid receptor binding | 2.87e-03 | 20 | 80 | 2 | GO:0035259 | |
| GeneOntologyMolecularFunction | peroxisome proliferator activated receptor binding | 3.17e-03 | 21 | 80 | 2 | GO:0042975 | |
| GeneOntologyMolecularFunction | nuclear retinoid X receptor binding | 3.80e-03 | 23 | 80 | 2 | GO:0046965 | |
| GeneOntologyMolecularFunction | histone H4 acetyltransferase activity | 3.80e-03 | 23 | 80 | 2 | GO:0010485 | |
| GeneOntologyMolecularFunction | RNA polymerase II core promoter sequence-specific DNA binding | 4.48e-03 | 25 | 80 | 2 | GO:0000979 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TBX22 NCOA2 FOXL2 NKX2-1 GLI2 AHR CHD7 SOX13 EP300 NOTCH1 TBP PASD1 | 4.54e-03 | 1271 | 80 | 12 | GO:0000987 |
| GeneOntologyMolecularFunction | poly(A) binding | 6.00e-03 | 29 | 80 | 2 | GO:0008143 | |
| GeneOntologyMolecularFunction | acetylation-dependent protein binding | 6.84e-03 | 31 | 80 | 2 | GO:0140033 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 8.18e-03 | 34 | 80 | 2 | GO:0046966 | |
| GeneOntologyMolecularFunction | transcription regulator inhibitor activity | 9.14e-03 | 36 | 80 | 2 | GO:0140416 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 9.64e-03 | 37 | 80 | 2 | GO:0070717 | |
| GeneOntologyMolecularFunction | bHLH transcription factor binding | 9.64e-03 | 37 | 80 | 2 | GO:0043425 | |
| GeneOntologyBiologicalProcess | head development | XRN2 TTBK1 ATXN2 NKX2-1 INHBB GLI2 KAT6A SMG9 NCOA1 CHD8 CITED1 CHD7 ZMIZ1 RRM1 ARID1A CREBBP EP300 NOTCH1 | 1.60e-08 | 919 | 82 | 18 | GO:0060322 |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 2.42e-07 | 4 | 82 | 3 | GO:1904017 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 1.20e-06 | 6 | 82 | 3 | GO:1904016 | |
| GeneOntologyBiologicalProcess | brain development | XRN2 TTBK1 ATXN2 NKX2-1 INHBB GLI2 SMG9 NCOA1 CHD8 CITED1 CHD7 ZMIZ1 RRM1 ARID1A NOTCH1 | 1.28e-06 | 859 | 82 | 15 | GO:0007420 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | USP36 ARID1B SS18L1 KAT6A AHR NCOA1 CHD8 BICRAL CHD7 RAD54L2 ARID1A TAF1L CREBBP JMJD1C EP300 TBP | 1.67e-06 | 999 | 82 | 16 | GO:0071824 |
| GeneOntologyBiologicalProcess | embryo development | SUPT20HL1 FOXL2 HTR2B AMOT GLI2 FURIN KAT6A SMG9 NCOA1 CHD8 SUPT20HL2 CITED1 CHD7 ZMIZ1 ARID1A CREBBP EP300 NOTCH1 RAI2 | 2.65e-06 | 1437 | 82 | 19 | GO:0009790 |
| GeneOntologyBiologicalProcess | reproductive structure development | 2.82e-06 | 383 | 82 | 10 | GO:0048608 | |
| GeneOntologyBiologicalProcess | reproductive system development | 3.17e-06 | 388 | 82 | 10 | GO:0061458 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | USP36 ARID1B KAT6A NCOA1 CHD8 BICRAL CHD7 RAD54L2 ARID1A TAF1L CREBBP JMJD1C EP300 | 6.78e-06 | 741 | 82 | 13 | GO:0006338 |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | NCOA2 SUPT20HL1 FOXL2 NKX2-1 GLI2 SS18L1 AHR NCOA1 CHD8 SUPT20HL2 CITED1 CHD7 ZMIZ1 RAD54L2 CREBBP EP300 NOTCH1 TBP | 6.86e-06 | 1390 | 82 | 18 | GO:0045944 |
| GeneOntologyBiologicalProcess | chromatin organization | USP36 ARID1B SS18L1 KAT6A NCOA1 CHD8 BICRAL CHD7 RAD54L2 ARID1A TAF1L CREBBP JMJD1C EP300 | 1.08e-05 | 896 | 82 | 14 | GO:0006325 |
| GeneOntologyBiologicalProcess | sex differentiation | 1.09e-05 | 352 | 82 | 9 | GO:0007548 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular response to transforming growth factor beta stimulus | 1.11e-05 | 35 | 82 | 4 | GO:1903846 | |
| GeneOntologyBiologicalProcess | positive regulation of transforming growth factor beta receptor signaling pathway | 1.11e-05 | 35 | 82 | 4 | GO:0030511 | |
| GeneOntologyBiologicalProcess | central nervous system development | XRN2 TTBK1 ATXN2 NKX2-1 INHBB GLI2 SMG9 NCOA1 CHD8 CITED1 CHD7 ZMIZ1 RRM1 ARID1A SOX13 NOTCH1 | 1.65e-05 | 1197 | 82 | 16 | GO:0007417 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | CRISP2 ARID1B RAP2B PCDHGB3 CDHR2 GLI2 RC3H1 ICAM2 ZMIZ1 ARID1A PCDHB1 SOX13 EP300 NOTCH1 PCDH17 | 1.97e-05 | 1077 | 82 | 15 | GO:0098609 |
| GeneOntologyBiologicalProcess | eye development | 2.03e-05 | 480 | 82 | 10 | GO:0001654 | |
| GeneOntologyBiologicalProcess | gonad development | 2.11e-05 | 292 | 82 | 8 | GO:0008406 | |
| GeneOntologyBiologicalProcess | visual system development | 2.14e-05 | 483 | 82 | 10 | GO:0150063 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 2.36e-05 | 144 | 82 | 6 | GO:0045582 | |
| GeneOntologyBiologicalProcess | forebrain development | 2.38e-05 | 489 | 82 | 10 | GO:0030900 | |
| GeneOntologyBiologicalProcess | development of primary sexual characteristics | 2.38e-05 | 297 | 82 | 8 | GO:0045137 | |
| GeneOntologyBiologicalProcess | sensory system development | 2.46e-05 | 491 | 82 | 10 | GO:0048880 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TBX22 NCOA2 FOXL2 NKX2-1 GLI2 KAT6A AHR CHD8 CITED1 ARID1A ZC3H6 CREBBP SOX13 EP300 NOTCH1 HEXIM2 PASD1 | 2.94e-05 | 1399 | 82 | 17 | GO:0045892 |
| GeneOntologyBiologicalProcess | sensory organ development | XRN2 FOXL2 ABI2 INHBB GLI2 AHR SMG9 CHD7 RRM1 ARID1A USH2A NOTCH1 | 3.02e-05 | 730 | 82 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 3.27e-05 | 226 | 82 | 7 | GO:0045580 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TBX22 NCOA2 FOXL2 NKX2-1 GLI2 KAT6A AHR CHD8 CITED1 ARID1A ZC3H6 CREBBP SOX13 EP300 NOTCH1 HEXIM2 PASD1 | 3.34e-05 | 1413 | 82 | 17 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of lymphocyte differentiation | 4.58e-05 | 162 | 82 | 6 | GO:0045621 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 6.80e-05 | 445 | 82 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | AMOT GLI2 FURIN SMG9 NCOA1 CHD8 CITED1 CHD7 ZMIZ1 ARID1A EP300 NOTCH1 RAI2 | 7.20e-05 | 929 | 82 | 13 | GO:0009792 |
| GeneOntologyBiologicalProcess | regulation of lymphocyte differentiation | 9.14e-05 | 266 | 82 | 7 | GO:0045619 | |
| GeneOntologyBiologicalProcess | rhythmic process | 9.23e-05 | 360 | 82 | 8 | GO:0048511 | |
| GeneOntologyBiologicalProcess | positive regulation of female receptivity | 9.32e-05 | 4 | 82 | 2 | GO:0045925 | |
| GeneOntologyBiologicalProcess | N-terminal peptidyl-lysine acetylation | 9.32e-05 | 4 | 82 | 2 | GO:0018076 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 9.57e-05 | 115 | 82 | 5 | GO:0090100 | |
| GeneOntologyBiologicalProcess | transcription initiation at RNA polymerase II promoter | 9.84e-05 | 186 | 82 | 6 | GO:0006367 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor signaling pathway | 1.15e-04 | 276 | 82 | 7 | GO:0007179 | |
| GeneOntologyBiologicalProcess | face development | 1.16e-04 | 63 | 82 | 4 | GO:0060324 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | SUPT20HL1 FOXL2 HTR2B AMOT GLI2 NCOA1 SUPT20HL2 CHD7 ARID1A CREBBP NOTCH1 | 1.17e-04 | 713 | 82 | 11 | GO:0048598 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta receptor signaling pathway | 1.17e-04 | 192 | 82 | 6 | GO:0017015 | |
| GeneOntologyBiologicalProcess | in utero embryonic development | 1.24e-04 | 596 | 82 | 10 | GO:0001701 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.25e-04 | 482 | 82 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to transforming growth factor beta stimulus | 1.27e-04 | 195 | 82 | 6 | GO:1903844 | |
| GeneOntologyBiologicalProcess | negative regulation of Wnt signaling pathway | 1.27e-04 | 195 | 82 | 6 | GO:0030178 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.39e-04 | 382 | 82 | 8 | GO:0030217 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 1.84e-04 | 71 | 82 | 4 | GO:0006111 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 1.96e-04 | 134 | 82 | 5 | GO:0010906 | |
| GeneOntologyBiologicalProcess | heart development | NPPA HTR2B GLI2 KAT6A AHR SMG9 CHD7 ZMIZ1 ARID1A EP300 NOTCH1 | 1.97e-04 | 757 | 82 | 11 | GO:0007507 |
| GeneOntologyBiologicalProcess | chordate embryonic development | AMOT GLI2 FURIN SMG9 NCOA1 CHD8 CITED1 CHD7 ZMIZ1 ARID1A EP300 NOTCH1 | 2.34e-04 | 906 | 82 | 12 | GO:0043009 |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | TBX22 NCOA2 FOXL2 NKX2-1 GLI2 AHR CHD8 ARID1A CREBBP SOX13 EP300 NOTCH1 HEXIM2 | 2.50e-04 | 1053 | 82 | 13 | GO:0000122 |
| GeneOntologyBiologicalProcess | positive regulation of gluconeogenesis | 2.76e-04 | 32 | 82 | 3 | GO:0045722 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 2.79e-04 | 537 | 82 | 9 | GO:0030098 | |
| GeneOntologyBiologicalProcess | camera-type eye development | 2.91e-04 | 426 | 82 | 8 | GO:0043010 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 3.18e-04 | 231 | 82 | 6 | GO:0006352 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 3.18e-04 | 231 | 82 | 6 | GO:0006109 | |
| GeneOntologyBiologicalProcess | growth involved in heart morphogenesis | 3.24e-04 | 7 | 82 | 2 | GO:0003241 | |
| GeneOntologyBiologicalProcess | positive regulation of follicle-stimulating hormone secretion | 3.24e-04 | 7 | 82 | 2 | GO:0046881 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 3.73e-04 | 154 | 82 | 5 | GO:0090090 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 3.82e-04 | 336 | 82 | 7 | GO:0071560 | |
| GeneOntologyBiologicalProcess | positive regulation of leukocyte differentiation | 4.08e-04 | 242 | 82 | 6 | GO:1902107 | |
| GeneOntologyBiologicalProcess | positive regulation of hemopoiesis | 4.08e-04 | 242 | 82 | 6 | GO:1903708 | |
| GeneOntologyBiologicalProcess | female sex differentiation | 4.08e-04 | 157 | 82 | 5 | GO:0046660 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte activation | ARID1B TTBK1 GLI2 RC3H1 SIGLEC10 AHR ZMIZ1 ARID1A SOX13 EP300 | 4.20e-04 | 694 | 82 | 10 | GO:0002694 |
| GeneOntologyBiologicalProcess | positive regulation of gonadotropin secretion | 4.30e-04 | 8 | 82 | 2 | GO:0032278 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 4.32e-04 | 343 | 82 | 7 | GO:0071559 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | FOXL2 HTR2B NKX2-1 ABI2 GLI2 KAT6A AHR CITED1 CHD7 ZMIZ1 ARID1A USH2A EP300 NOTCH1 | 4.44e-04 | 1269 | 82 | 14 | GO:0009887 |
| GeneOntologyBiologicalProcess | diencephalon development | 4.57e-04 | 90 | 82 | 4 | GO:0021536 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 4.63e-04 | 347 | 82 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 4.97e-04 | 92 | 82 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | carbon catabolite regulation of transcription from RNA polymerase II promoter | 5.52e-04 | 9 | 82 | 2 | GO:0000429 | |
| GeneOntologyBiologicalProcess | regulation of female receptivity | 5.52e-04 | 9 | 82 | 2 | GO:0045924 | |
| GeneOntologyBiologicalProcess | regulation of follicle-stimulating hormone secretion | 5.52e-04 | 9 | 82 | 2 | GO:0046880 | |
| GeneOntologyBiologicalProcess | face morphogenesis | 5.79e-04 | 41 | 82 | 3 | GO:0060325 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 5.79e-04 | 41 | 82 | 3 | GO:0035909 | |
| GeneOntologyBiologicalProcess | male gonad development | 6.02e-04 | 171 | 82 | 5 | GO:0008584 | |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | 6.03e-04 | 727 | 82 | 10 | GO:0032870 | |
| GeneOntologyBiologicalProcess | development of primary male sexual characteristics | 6.18e-04 | 172 | 82 | 5 | GO:0046546 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 6.22e-04 | 42 | 82 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | germ-line stem cell population maintenance | 6.88e-04 | 10 | 82 | 2 | GO:0030718 | |
| GeneOntologyBiologicalProcess | carbon catabolite regulation of transcription | 6.88e-04 | 10 | 82 | 2 | GO:0045990 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 7.13e-04 | 44 | 82 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | regulation of lymphocyte activation | 7.33e-04 | 614 | 82 | 9 | GO:0051249 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | 7.33e-04 | 614 | 82 | 9 | GO:0010720 | |
| GeneOntologyBiologicalProcess | pituitary gland development | 7.62e-04 | 45 | 82 | 3 | GO:0021983 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | NPPA ZFYVE9 NKX2-1 INHBB FURIN SIK2 CITED1 ZMIZ1 ERBIN CREBBP EP300 NOTCH1 PLCE1 | 7.72e-04 | 1186 | 82 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | behavior | NCOA2 TTBK1 HTR2B NKX2-1 ABI2 NCOA1 CHD8 CHD7 CREBBP EP300 PCDH17 | 7.80e-04 | 891 | 82 | 11 | GO:0007610 |
| GeneOntologyBiologicalProcess | regulation of cell activation | ARID1B TTBK1 GLI2 RC3H1 SIGLEC10 AHR ZMIZ1 ARID1A SOX13 EP300 | 8.14e-04 | 756 | 82 | 10 | GO:0050865 |
| GeneOntologyBiologicalProcess | follicle-stimulating hormone secretion | 8.39e-04 | 11 | 82 | 2 | GO:0046884 | |
| GeneOntologyBiologicalProcess | head morphogenesis | 9.21e-04 | 48 | 82 | 3 | GO:0060323 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 9.83e-04 | 640 | 82 | 9 | GO:1903131 | |
| GeneOntologyBiologicalProcess | female mating behavior | 1.00e-03 | 12 | 82 | 2 | GO:0060180 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 1.01e-03 | 111 | 82 | 4 | GO:0006094 | |
| GeneOntologyBiologicalProcess | response to interleukin-1 | 1.04e-03 | 112 | 82 | 4 | GO:0070555 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell activation | 1.05e-03 | 290 | 82 | 6 | GO:0050870 | |
| GeneOntologyBiologicalProcess | androgen receptor signaling pathway | 1.10e-03 | 51 | 82 | 3 | GO:0030521 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 1.15e-03 | 115 | 82 | 4 | GO:0019319 | |
| GeneOntologyBiologicalProcess | mRNA transcription by RNA polymerase II | 1.16e-03 | 52 | 82 | 3 | GO:0042789 | |
| GeneOntologyBiologicalProcess | tube development | NKX2-1 INHBB AMOT GLI2 KAT6A AHR CHD8 CITED1 CHD7 ZMIZ1 ARID1A JMJD1C EP300 NOTCH1 | 1.18e-03 | 1402 | 82 | 14 | GO:0035295 |
| GeneOntologyBiologicalProcess | male sex differentiation | 1.19e-03 | 199 | 82 | 5 | GO:0046661 | |
| GeneOntologyBiologicalProcess | biological phase | 1.23e-03 | 53 | 82 | 3 | GO:0044848 | |
| GeneOntologyCellularComponent | chromatin | TBX22 NCOA2 SUPT20HL1 ARID1B FOXL2 NKX2-1 SS18L1 KAT6A AHR NCOA1 CHD8 SUPT20HL2 BICRAL CHD7 ZMIZ1 ARID1A TAF1L ZC3H6 CREBBP SOX13 JMJD1C EP300 TBP | 6.85e-09 | 1480 | 82 | 23 | GO:0000785 |
| GeneOntologyCellularComponent | nBAF complex | 3.14e-05 | 16 | 82 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 3.43e-05 | 94 | 82 | 5 | GO:0000123 | |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 5.57e-05 | 104 | 82 | 5 | GO:0031248 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 6.97e-05 | 109 | 82 | 5 | GO:1902493 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 2.19e-04 | 30 | 82 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | NCOA2 ARID1B AMOT SS18L1 AHR NCOA1 CHD8 BICRAL ARID1A TAF1L CREBBP JMJD1C MX2 TBP PASD1 | 2.68e-04 | 1377 | 82 | 15 | GO:0140513 |
| GeneOntologyCellularComponent | transcription regulator complex | 5.39e-04 | 596 | 82 | 9 | GO:0005667 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 5.55e-04 | 96 | 82 | 4 | GO:0070603 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 5.55e-04 | 96 | 82 | 4 | GO:0010494 | |
| GeneOntologyCellularComponent | bBAF complex | 6.70e-04 | 10 | 82 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | RNA polymerase II transcription regulator complex | 7.03e-04 | 272 | 82 | 6 | GO:0090575 | |
| GeneOntologyCellularComponent | nuclear body | USP36 NCOA2 AMER1 GLI2 SS18L1 KAT6A RAD54L2 ERBIN CREBBP HEXIM2 PASD1 | 7.80e-04 | 903 | 82 | 11 | GO:0016604 |
| GeneOntologyCellularComponent | npBAF complex | 1.34e-03 | 14 | 82 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.34e-03 | 14 | 82 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nuclear speck | 1.52e-03 | 431 | 82 | 7 | GO:0016607 | |
| GeneOntologyCellularComponent | ATPase complex | 1.67e-03 | 129 | 82 | 4 | GO:1904949 | |
| HumanPheno | Abnormality of the helix | 5.35e-06 | 183 | 29 | 8 | HP:0000380 | |
| HumanPheno | Aplasia/Hypoplasia of toe | 9.59e-06 | 140 | 29 | 7 | HP:0001991 | |
| HumanPheno | Aplasia/Hypoplasia of the earlobes | 9.89e-06 | 53 | 29 | 5 | HP:0009906 | |
| HumanPheno | Congenital malformation of the great arteries | ARID1B AMER1 GLI2 KAT6A SMG9 CHD7 ZMIZ1 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 1.37e-05 | 529 | 29 | 12 | HP:0011603 |
| HumanPheno | Abnormal helix morphology | 1.59e-05 | 212 | 29 | 8 | HP:0011039 | |
| HumanPheno | Sporadic | 1.92e-05 | 103 | 29 | 6 | HP:0003745 | |
| HumanPheno | Abnormal aortic arch morphology | 2.66e-05 | 109 | 29 | 6 | HP:0012303 | |
| HumanPheno | Plantar crease between first and second toes | 3.13e-05 | 2 | 29 | 2 | HP:0008107 | |
| HumanPheno | Cerebellar Purkinje layer atrophy | 3.13e-05 | 2 | 29 | 2 | HP:0012082 | |
| HumanPheno | Aortic isthmus hypoplasia | 3.13e-05 | 2 | 29 | 2 | HP:0034227 | |
| HumanPheno | High axial triradius | 3.13e-05 | 2 | 29 | 2 | HP:0001042 | |
| HumanPheno | Ventricular septal defect | ARID1B AMER1 NKX2-1 KAT6A SMG9 CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 5.87e-05 | 510 | 29 | 11 | HP:0001629 |
| HumanPheno | Epicanthus | TBX22 ARID1B AMER1 FOXL2 GLI2 KAT6A CHD8 CHD7 ZMIZ1 CREBBP JMJD1C EP300 | 6.26e-05 | 614 | 29 | 12 | HP:0000286 |
| HumanPheno | Abnormal judgment | ATXN2 NKX2-1 GLI2 CHD8 CHD7 DNAJC6 USH2A CREBBP JMJD1C EP300 TBP | 6.55e-05 | 516 | 29 | 11 | HP:5200401 |
| HumanPheno | Abnormal cardiac atrium morphology | TBX22 NPPA ARID1B AMER1 NKX2-1 KAT6A CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 6.57e-05 | 617 | 29 | 12 | HP:0005120 |
| HumanPheno | Abnormal ventricular septum morphology | ARID1B AMER1 NKX2-1 KAT6A SMG9 CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 7.16e-05 | 521 | 29 | 11 | HP:0010438 |
| HumanPheno | Square face | 8.84e-05 | 16 | 29 | 3 | HP:0000321 | |
| HumanPheno | Laryngeal cartilage malformation | 9.36e-05 | 3 | 29 | 2 | HP:0008752 | |
| HumanPheno | Phobia | 9.36e-05 | 3 | 29 | 2 | HP:5200232 | |
| HumanPheno | Agoraphobia | 9.36e-05 | 3 | 29 | 2 | HP:0000756 | |
| HumanPheno | Humoral immunodeficiency | 9.36e-05 | 3 | 29 | 2 | HP:0005363 | |
| HumanPheno | Prominent nasal septum | 9.36e-05 | 3 | 29 | 2 | HP:0005322 | |
| HumanPheno | Radial deviation of thumb terminal phalanx | 9.36e-05 | 3 | 29 | 2 | HP:0005895 | |
| HumanPheno | Laryngomalacia | 9.41e-05 | 84 | 29 | 5 | HP:0001601 | |
| HumanPheno | Abnormal earlobe morphology | 9.67e-05 | 137 | 29 | 6 | HP:0000363 | |
| HumanPheno | Atrial septal defect | TBX22 ARID1B AMER1 NKX2-1 KAT6A CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 1.01e-04 | 541 | 29 | 11 | HP:0001631 |
| HumanPheno | Abnormality of the atrial septum | TBX22 ARID1B AMER1 NKX2-1 KAT6A CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 1.01e-04 | 541 | 29 | 11 | HP:0001630 |
| HumanPheno | Abnormal atrial septum morphology | TBX22 ARID1B AMER1 NKX2-1 KAT6A CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 1.07e-04 | 544 | 29 | 11 | HP:0011994 |
| HumanPheno | Short stepped shuffling gait | 1.07e-04 | 17 | 29 | 3 | HP:0007311 | |
| HumanPheno | Abnormal nasolacrimal system morphology | 1.11e-04 | 87 | 29 | 5 | HP:0000614 | |
| HumanPheno | Abnormal lacrimal duct morphology | 1.63e-04 | 50 | 29 | 4 | HP:0011481 | |
| HumanPheno | Constipation | 1.68e-04 | 472 | 29 | 10 | HP:0002019 | |
| HumanPheno | Patent ductus arteriosus | 1.77e-04 | 382 | 29 | 9 | HP:0001643 | |
| HumanPheno | Sandal gap | 1.78e-04 | 96 | 29 | 5 | HP:0001852 | |
| HumanPheno | Trichiasis | 1.86e-04 | 4 | 29 | 2 | HP:0001128 | |
| HumanPheno | Visceral hemangioma | 1.86e-04 | 4 | 29 | 2 | HP:0410266 | |
| HumanPheno | Talon cusp | 1.86e-04 | 4 | 29 | 2 | HP:0011087 | |
| HumanPheno | Widened distal phalanges | 1.86e-04 | 4 | 29 | 2 | HP:0006200 | |
| HumanPheno | Vascular ring | 1.86e-04 | 4 | 29 | 2 | HP:0010775 | |
| HumanPheno | Hepatic hemangioma | 1.86e-04 | 4 | 29 | 2 | HP:0031207 | |
| HumanPheno | Abnormal columella morphology | 1.87e-04 | 97 | 29 | 5 | HP:0009929 | |
| HumanPheno | Abnormality of tear glands or tear production | 1.98e-04 | 156 | 29 | 6 | HP:0000521 | |
| HumanPheno | Maladaptive fear-related cognitions | ATXN2 NKX2-1 GLI2 CHD8 CHD7 DNAJC6 USH2A CREBBP JMJD1C EP300 | 2.04e-04 | 483 | 29 | 10 | HP:5200230 |
| HumanPheno | Anxiety | ATXN2 NKX2-1 GLI2 CHD8 CHD7 DNAJC6 USH2A CREBBP JMJD1C EP300 | 2.04e-04 | 483 | 29 | 10 | HP:0000739 |
| HumanPheno | Intestinal malrotation | 2.05e-04 | 157 | 29 | 6 | HP:0002566 | |
| HumanPheno | Localized hirsutism | 2.06e-04 | 21 | 29 | 3 | HP:0009889 | |
| HumanPheno | Dislocated radial head | 2.20e-04 | 54 | 29 | 4 | HP:0003083 | |
| HumanPheno | Pneumonia | 2.44e-04 | 311 | 29 | 8 | HP:0002090 | |
| HumanPheno | Low hanging columella | 2.54e-04 | 56 | 29 | 4 | HP:0009765 | |
| HumanPheno | Abnormality of the radial head | 2.72e-04 | 57 | 29 | 4 | HP:0003995 | |
| HumanPheno | Papillary cystadenoma of the epididymis | 3.10e-04 | 5 | 29 | 2 | HP:0009715 | |
| HumanPheno | Supernumerary cusp | 3.10e-04 | 5 | 29 | 2 | HP:0033777 | |
| HumanPheno | Epididymal neoplasm | 3.10e-04 | 5 | 29 | 2 | HP:0030421 | |
| HumanPheno | Papillary thyroid carcinoma | 3.10e-04 | 24 | 29 | 3 | HP:0002895 | |
| HumanPheno | Abnormal skull base morphology | 3.18e-04 | 242 | 29 | 7 | HP:0002693 | |
| HumanPheno | Abnormal neural tube morphology | 3.24e-04 | 324 | 29 | 8 | HP:0410043 | |
| HumanPheno | Neural tube defect | 3.24e-04 | 324 | 29 | 8 | HP:0045005 | |
| HumanPheno | Spina bifida | 3.27e-04 | 171 | 29 | 6 | HP:0002414 | |
| HumanPheno | Aggressive behavior | 3.52e-04 | 516 | 29 | 10 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 3.52e-04 | 516 | 29 | 10 | HP:0006919 | |
| HumanPheno | Abnormal morphology of the great vessels | ARID1B AMER1 GLI2 KAT6A SMG9 CHD7 ZMIZ1 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 3.68e-04 | 736 | 29 | 12 | HP:0030962 |
| HumanPheno | Abnormality of the humeroradial joint | 3.76e-04 | 62 | 29 | 4 | HP:0100744 | |
| HumanPheno | Feeding difficulties | ARID1B MECR ATXN2 GLI2 KAT6A CHD8 CHD7 ZMIZ1 RRM1 ARID1A CREBBP JMJD1C EP300 TBP | 3.81e-04 | 982 | 29 | 14 | HP:0002022 |
| HumanPheno | Large fontanelles | 3.82e-04 | 176 | 29 | 6 | HP:0000239 | |
| HumanPheno | Abnormal nasal septum morphology | 4.14e-04 | 115 | 29 | 5 | HP:0000419 | |
| HumanPheno | Short philtrum | 4.17e-04 | 253 | 29 | 7 | HP:0000322 | |
| HumanPheno | Short toe | 4.31e-04 | 116 | 29 | 5 | HP:0001831 | |
| HumanPheno | Flared iliac wing | 4.43e-04 | 27 | 29 | 3 | HP:0002869 | |
| HumanPheno | Complex cardiac malformations | 4.59e-04 | 257 | 29 | 7 | HP:0002565 | |
| HumanPheno | Ptosis | ARID1B FOXL2 GLI2 KAT6A CHD8 CHD7 ZMIZ1 RRM1 ARID1A CREBBP JMJD1C EP300 | 4.63e-04 | 754 | 29 | 12 | HP:0000508 |
| HumanPheno | Large foramen magnum | 4.63e-04 | 6 | 29 | 2 | HP:0002700 | |
| HumanPheno | Abnormal fear-induced behavior | ATXN2 NKX2-1 GLI2 CHD8 CHD7 DNAJC6 USH2A CREBBP JMJD1C EP300 | 4.94e-04 | 538 | 29 | 10 | HP:0100852 |
| HumanPheno | Abnormal experience of reality | ATXN2 NKX2-1 GLI2 CHD8 CHD7 DNAJC6 USH2A CREBBP JMJD1C EP300 TBP | 4.99e-04 | 646 | 29 | 11 | HP:5200423 |
| HumanPheno | Tetralogy of Fallot | 5.00e-04 | 185 | 29 | 6 | HP:0001636 | |
| HumanPheno | Impairment in personality functioning | ARID1B TIA1 ATXN2 NKX2-1 GLI2 CHD8 CHD7 ZMIZ1 ARID1A DNAJC6 USH2A CREBBP JMJD1C EP300 TBP | 5.07e-04 | 1141 | 29 | 15 | HP:0031466 |
| HumanPheno | Spinal dysraphism | 5.15e-04 | 186 | 29 | 6 | HP:0010301 | |
| HumanPheno | Lewy bodies | 6.08e-04 | 30 | 29 | 3 | HP:0100315 | |
| HumanPheno | Abnormality of the middle ear | TBX22 NPPA ARID1B AMER1 OSBPL2 MECR NKX2-1 GLI2 KAT6A AHR SMG9 CHD7 RRM1 USH2A CREBBP JMJD1C EP300 | 6.16e-04 | 1446 | 29 | 17 | HP:0000370 |
| HumanPheno | Abnormal cardiac ventricle morphology | NPPA ARID1B AMER1 NKX2-1 KAT6A SMG9 CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 6.36e-04 | 780 | 29 | 12 | HP:0001713 |
| HumanPheno | Deviated nasal septum | 6.46e-04 | 7 | 29 | 2 | HP:0004411 | |
| HumanPheno | Underdeveloped tragus | 6.46e-04 | 7 | 29 | 2 | HP:0011272 | |
| HumanPheno | Hyperactivity | ARID1B NKX2-1 GLI2 CHD8 CHD7 ZMIZ1 ARID1A CREBBP JMJD1C EP300 | 6.63e-04 | 558 | 29 | 10 | HP:0000752 |
| HumanPheno | Weak voice | 6.70e-04 | 31 | 29 | 3 | HP:0001621 | |
| HumanPheno | Abnormal cardiac septum morphology | TBX22 ARID1B AMER1 NKX2-1 KAT6A SMG9 CHD7 ARID1A CREBBP JMJD1C EP300 NOTCH1 | 6.91e-04 | 787 | 29 | 12 | HP:0001671 |
| HumanPheno | Abnormal aortic morphology | 6.99e-04 | 363 | 29 | 8 | HP:0030963 | |
| HumanPheno | Abnormal pulmonary valve morphology | 7.18e-04 | 198 | 29 | 6 | HP:0001641 | |
| HumanPheno | Aplasia of the toes | 7.40e-04 | 74 | 29 | 4 | HP:0011306 | |
| HumanPheno | Absent toe | 7.40e-04 | 74 | 29 | 4 | HP:0010760 | |
| HumanPheno | Abnormal ventriculoarterial connection | 7.70e-04 | 280 | 29 | 7 | HP:0011563 | |
| HumanPheno | Abnormal larynx morphology | 7.77e-04 | 201 | 29 | 6 | HP:0025423 | |
| HumanPheno | Abnormal branching pattern of the aortic arch | 8.07e-04 | 33 | 29 | 3 | HP:0011587 | |
| HumanPheno | Conductive hearing impairment | 8.37e-04 | 373 | 29 | 8 | HP:0000405 | |
| HumanPheno | Abnormal connection of the cardiac segments | 8.39e-04 | 284 | 29 | 7 | HP:0011545 | |
| HumanPheno | Aplasia/Hypoplasia of the tragus | 8.58e-04 | 8 | 29 | 2 | HP:0009913 | |
| HumanPheno | Gonadotropin deficiency | 8.58e-04 | 8 | 29 | 2 | HP:0008213 | |
| HumanPheno | Abnormal lacrimal punctum morphology | 8.58e-04 | 8 | 29 | 2 | HP:0011479 | |
| HumanPheno | Spina bifida occulta | 8.61e-04 | 77 | 29 | 4 | HP:0003298 | |
| HumanPheno | Disinhibition | ARID1B NKX2-1 GLI2 CHD8 CHD7 ZMIZ1 ARID1A DNAJC6 CREBBP JMJD1C EP300 TBP | 8.73e-04 | 807 | 29 | 12 | HP:0000734 |
| HumanPheno | Inappropriate behavior | ARID1B NKX2-1 GLI2 CHD8 CHD7 ZMIZ1 ARID1A DNAJC6 CREBBP JMJD1C EP300 TBP | 8.73e-04 | 807 | 29 | 12 | HP:0000719 |
| HumanPheno | Abnormal response to social norms | ARID1B NKX2-1 GLI2 CHD8 CHD7 ZMIZ1 ARID1A DNAJC6 CREBBP JMJD1C EP300 TBP | 8.73e-04 | 807 | 29 | 12 | HP:5200123 |
| MousePheno | abnormal vascular development | SUPT20HL1 MECR AMOT FURIN KAT6A AHR SMG9 SUPT20HL2 CHD7 ZMIZ1 ARID1A CREBBP EP300 NOTCH1 | 1.77e-07 | 542 | 66 | 14 | MP:0000259 |
| MousePheno | abnormal cardiovascular development | SUPT20HL1 HTR2B MECR AMOT FURIN KAT6A AHR SMG9 SUPT20HL2 CHD7 ZMIZ1 ARID1A CREBBP EP300 NOTCH1 PLCE1 | 6.79e-07 | 802 | 66 | 16 | MP:0002925 |
| MousePheno | abnormal vitelline vasculature morphology | SUPT20HL1 MECR AMOT FURIN SUPT20HL2 ZMIZ1 CREBBP EP300 NOTCH1 | 1.48e-06 | 235 | 66 | 9 | MP:0003229 |
| MousePheno | abnormal prenatal growth/weight/body size | SUPT20HL1 AMER1 HTR2B MECR NKX2-1 AMOT GLI2 FURIN KAT6A SMG9 SUPT20HL2 BICRAL CITED1 CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 TBP | 2.70e-06 | 1493 | 66 | 21 | MP:0004196 |
| MousePheno | abnormal left-right axis symmetry of the somites | 5.54e-06 | 8 | 66 | 3 | MP:0005224 | |
| MousePheno | abnormal blood vessel morphology | NCOA2 SUPT20HL1 NPPA ARID1B MECR NKX2-1 INHBB AMOT FURIN KAT6A AHR SMG9 SUPT20HL2 CITED1 CHD7 ZMIZ1 ARID1A CREBBP EP300 NOTCH1 | 8.60e-06 | 1472 | 66 | 20 | MP:0001614 |
| MousePheno | abnormal visceral yolk sac morphology | 1.45e-05 | 236 | 66 | 8 | MP:0001718 | |
| MousePheno | abnormal embryonic tissue morphology | SUPT20HL1 AMER1 GLI2 RC3H1 FURIN KAT6A SMG9 CHD8 SUPT20HL2 CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 4.59e-05 | 1116 | 66 | 16 | MP:0002085 |
| MousePheno | abnormal prenatal body size | AMER1 HTR2B MECR NKX2-1 AMOT GLI2 FURIN KAT6A SMG9 CITED1 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 4.59e-05 | 1116 | 66 | 16 | MP:0010866 |
| MousePheno | embryonic lethality during organogenesis | HTR2B MECR AMOT FURIN CHD8 BICRAL CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 TBP | 4.71e-05 | 876 | 66 | 14 | MP:0006207 |
| MousePheno | interrupted aortic arch, type b | 5.39e-05 | 16 | 66 | 3 | MP:0011659 | |
| MousePheno | abnormal heart development | 5.89e-05 | 372 | 66 | 9 | MP:0000267 | |
| MousePheno | abnormal angiogenesis | 5.89e-05 | 372 | 66 | 9 | MP:0000260 | |
| MousePheno | abnormal pharyngeal arch artery morphology | 6.94e-05 | 47 | 66 | 4 | MP:0002672 | |
| MousePheno | abnormal extraembryonic tissue morphology | NCOA2 SUPT20HL1 MECR AMOT FURIN SMG9 SUPT20HL2 CITED1 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 6.96e-05 | 908 | 66 | 14 | MP:0002086 |
| MousePheno | abnormal developmental patterning | SUPT20HL1 AMOT GLI2 FURIN CHD8 SUPT20HL2 BICRAL CHD7 ARID1A EP300 NOTCH1 | 7.34e-05 | 577 | 66 | 11 | MP:0002084 |
| MousePheno | abnormal neurohypophysis morphology | 7.80e-05 | 18 | 66 | 3 | MP:0004164 | |
| MousePheno | abnormal neural tube morphology | SUPT20HL1 GLI2 RC3H1 FURIN SUPT20HL2 CHD7 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 9.09e-05 | 591 | 66 | 11 | MP:0002151 |
| MousePheno | exencephaly | 1.02e-04 | 230 | 66 | 7 | MP:0000914 | |
| MousePheno | abnormal gland development | 1.10e-04 | 233 | 66 | 7 | MP:0020973 | |
| MousePheno | absent myocardial trabeculae | 1.45e-04 | 22 | 66 | 3 | MP:0000293 | |
| MousePheno | abnormal embryo development | USP36 SUPT20HL1 HTR2B MECR AMOT GLI2 FURIN CHD8 SUPT20HL2 BICRAL CHD7 RAD54L2 ARID1A CREBBP EP300 NOTCH1 TBP | 1.53e-04 | 1370 | 66 | 17 | MP:0001672 |
| MousePheno | pale yolk sac | 1.68e-04 | 110 | 66 | 5 | MP:0001722 | |
| MousePheno | prenatal growth retardation | SUPT20HL1 HTR2B MECR AMOT SMG9 SUPT20HL2 BICRAL CHD7 RAD54L2 CREBBP EP300 NOTCH1 TBP | 1.78e-04 | 869 | 66 | 13 | MP:0010865 |
| MousePheno | embryonic growth arrest | 2.14e-04 | 346 | 66 | 8 | MP:0001730 | |
| MousePheno | decreased embryo size | HTR2B MECR AMOT GLI2 FURIN ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 2.37e-04 | 659 | 66 | 11 | MP:0001698 |
| MousePheno | abnormal embryonic growth/weight/body size | SUPT20HL1 HTR2B MECR AMOT GLI2 FURIN SMG9 SUPT20HL2 BICRAL CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 2.65e-04 | 1295 | 66 | 16 | MP:0002088 |
| MousePheno | postnatal lethality, incomplete penetrance | FOXL2 HTR2B TIA1 INHBB GLI2 AHR CHD7 DNAJC6 CREBBP EP300 TBP | 2.69e-04 | 669 | 66 | 11 | MP:0011086 |
| MousePheno | cleft secondary palate | 3.28e-04 | 127 | 66 | 5 | MP:0009890 | |
| MousePheno | abnormal secretory circumventricular organ morphology | 3.36e-04 | 29 | 66 | 3 | MP:0013563 | |
| MousePheno | abnormal rostral-caudal axis patterning | 3.92e-04 | 132 | 66 | 5 | MP:0005221 | |
| MousePheno | abnormal placenta physiology | 3.94e-04 | 204 | 66 | 6 | MP:0010038 | |
| MousePheno | embryonic lethality during organogenesis, complete penetrance | MECR FURIN CHD8 BICRAL CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 3.97e-04 | 700 | 66 | 11 | MP:0011098 |
| MousePheno | abnormal artery development | 4.06e-04 | 133 | 66 | 5 | MP:0003410 | |
| MousePheno | abnormal circumventricular organ morphology | 4.11e-04 | 31 | 66 | 3 | MP:0013562 | |
| MousePheno | abnormal internal nares morphology | 4.54e-04 | 7 | 66 | 2 | MP:0002236 | |
| MousePheno | abnormal blood circulation | NPPA MECR NKX2-1 AMOT KAT6A SMG9 CHD7 ARID1A CREBBP EP300 NOTCH1 TBP | 5.26e-04 | 845 | 66 | 12 | MP:0002128 |
| MousePheno | increased spongiotrophoblast size | 6.04e-04 | 8 | 66 | 2 | MP:0012098 | |
| MousePheno | chronic liver inflammation | 6.04e-04 | 8 | 66 | 2 | MP:0031301 | |
| MousePheno | abnormal nervous system development | SUPT20HL1 ARID1B GLI2 RC3H1 FURIN SMG9 NCOA1 CHD8 SUPT20HL2 CHD7 RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 6.21e-04 | 1257 | 66 | 15 | MP:0003861 |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | TBX22 FOXL2 HTR2B TIA1 INHBB GLI2 AHR SMG9 CITED1 CHD7 DNAJC6 CREBBP EP300 TBP | 6.40e-04 | 1124 | 66 | 14 | MP:0011112 |
| MousePheno | abnormal heart atrium morphology | 7.75e-04 | 232 | 66 | 6 | MP:0003105 | |
| MousePheno | embryonic growth retardation | SUPT20HL1 HTR2B MECR AMOT SUPT20HL2 BICRAL CHD7 RAD54L2 CREBBP EP300 NOTCH1 | 8.16e-04 | 763 | 66 | 11 | MP:0003984 |
| MousePheno | abnormal secondary palate morphology | 9.13e-04 | 159 | 66 | 5 | MP:0013550 | |
| MousePheno | abnormal placenta development | 9.40e-04 | 160 | 66 | 5 | MP:0001712 | |
| MousePheno | abnormal respiratory system development | 9.40e-04 | 160 | 66 | 5 | MP:0003115 | |
| MousePheno | interrupted aortic arch | 9.43e-04 | 41 | 66 | 3 | MP:0004157 | |
| MousePheno | abnormal gastrulation movements | 9.64e-04 | 10 | 66 | 2 | MP:0002174 | |
| MousePheno | disorganized placental labyrinth | 9.64e-04 | 10 | 66 | 2 | MP:0011527 | |
| MousePheno | abnormal heart valve morphology | 1.02e-03 | 163 | 66 | 5 | MP:0000285 | |
| MousePheno | hemorrhage | 1.04e-03 | 664 | 66 | 10 | MP:0001914 | |
| MousePheno | interrupted aorta | 1.08e-03 | 43 | 66 | 3 | MP:0010544 | |
| MousePheno | abnormal heart ventricle morphology | NPPA HTR2B KAT6A SMG9 CHD7 ARID1A CREBBP EP300 NOTCH1 RAI2 PLCE1 | 1.12e-03 | 793 | 66 | 11 | MP:0005294 |
| MousePheno | incomplete somite formation | 1.16e-03 | 44 | 66 | 3 | MP:0001689 | |
| MousePheno | abnormal embryo turning | 1.17e-03 | 251 | 66 | 6 | MP:0001700 | |
| MousePheno | abnormal extraembryonic tissue physiology | 1.17e-03 | 345 | 66 | 7 | MP:0004264 | |
| Domain | Nuc_rcpt_coact | 4.65e-09 | 6 | 80 | 4 | IPR009110 | |
| Domain | PAS | 1.02e-05 | 32 | 80 | 4 | SM00091 | |
| Domain | PAS | 1.31e-05 | 34 | 80 | 4 | IPR000014 | |
| Domain | PAS | 1.31e-05 | 34 | 80 | 4 | PS50112 | |
| Domain | BAF250_C | 1.81e-05 | 2 | 80 | 2 | IPR033388 | |
| Domain | Nuc_rcpt_coact_CREBbp | 1.81e-05 | 2 | 80 | 2 | IPR014744 | |
| Domain | HAT_KAT11 | 1.81e-05 | 2 | 80 | 2 | PF08214 | |
| Domain | KIX | 1.81e-05 | 2 | 80 | 2 | PS50952 | |
| Domain | ZnF_TAZ | 1.81e-05 | 2 | 80 | 2 | SM00551 | |
| Domain | CBP_P300_HAT | 1.81e-05 | 2 | 80 | 2 | IPR031162 | |
| Domain | DUF902 | 1.81e-05 | 2 | 80 | 2 | PF06001 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.20.1020.10 | |
| Domain | RING_CBP-p300 | 1.81e-05 | 2 | 80 | 2 | IPR010303 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.10.1630.10 | |
| Domain | Creb_binding | 1.81e-05 | 2 | 80 | 2 | PF09030 | |
| Domain | - | 1.81e-05 | 2 | 80 | 2 | 1.10.246.20 | |
| Domain | zf-TAZ | 1.81e-05 | 2 | 80 | 2 | PF02135 | |
| Domain | ZF_TAZ | 1.81e-05 | 2 | 80 | 2 | PS50134 | |
| Domain | BAF250_C | 1.81e-05 | 2 | 80 | 2 | PF12031 | |
| Domain | Histone_AcTrfase_Rtt109/CBP | 1.81e-05 | 2 | 80 | 2 | IPR013178 | |
| Domain | BAF250/Osa | 1.81e-05 | 2 | 80 | 2 | IPR021906 | |
| Domain | KAT11 | 1.81e-05 | 2 | 80 | 2 | SM01250 | |
| Domain | Znf_TAZ | 1.81e-05 | 2 | 80 | 2 | IPR000197 | |
| Domain | KIX_dom | 1.81e-05 | 2 | 80 | 2 | IPR003101 | |
| Domain | KIX | 1.81e-05 | 2 | 80 | 2 | PF02172 | |
| Domain | CBP_P300_HAT | 1.81e-05 | 2 | 80 | 2 | PS51727 | |
| Domain | DUF1518 | 5.42e-05 | 3 | 80 | 2 | PF07469 | |
| Domain | DUF1518 | 5.42e-05 | 3 | 80 | 2 | IPR010011 | |
| Domain | Nuc_rcpt_coact_Ncoa-typ | 5.42e-05 | 3 | 80 | 2 | IPR014920 | |
| Domain | SRC-1 | 5.42e-05 | 3 | 80 | 2 | IPR014935 | |
| Domain | SUZ | 5.42e-05 | 3 | 80 | 2 | PF12752 | |
| Domain | Src1_rcpt_coact | 5.42e-05 | 3 | 80 | 2 | IPR008955 | |
| Domain | Nuclear_rcpt_coactivator | 5.42e-05 | 3 | 80 | 2 | IPR017426 | |
| Domain | DUF1518 | 5.42e-05 | 3 | 80 | 2 | SM01151 | |
| Domain | SRC-1 | 5.42e-05 | 3 | 80 | 2 | PF08832 | |
| Domain | - | 5.42e-05 | 3 | 80 | 2 | 4.10.630.10 | |
| Domain | Nuc_rec_co-act | 5.42e-05 | 3 | 80 | 2 | PF08815 | |
| Domain | SUZ | 1.08e-04 | 4 | 80 | 2 | IPR024771 | |
| Domain | SUZ | 1.08e-04 | 4 | 80 | 2 | PS51673 | |
| Domain | PAS | 1.63e-04 | 25 | 80 | 3 | PF00989 | |
| Domain | PAS_fold | 1.63e-04 | 25 | 80 | 3 | IPR013767 | |
| Domain | Bromodomain_CS | 1.83e-04 | 26 | 80 | 3 | IPR018359 | |
| Domain | BRK | 2.69e-04 | 6 | 80 | 2 | SM00592 | |
| Domain | BRK_domain | 2.69e-04 | 6 | 80 | 2 | IPR006576 | |
| Domain | BRK | 2.69e-04 | 6 | 80 | 2 | PF07533 | |
| Domain | SNF2_N | 3.43e-04 | 32 | 80 | 3 | IPR000330 | |
| Domain | SNF2_N | 3.43e-04 | 32 | 80 | 3 | PF00176 | |
| Domain | BROMODOMAIN_1 | 5.29e-04 | 37 | 80 | 3 | PS00633 | |
| Domain | Bromodomain | 5.73e-04 | 38 | 80 | 3 | PF00439 | |
| Domain | R3H | 6.40e-04 | 9 | 80 | 2 | SM00393 | |
| Domain | BROMODOMAIN_2 | 7.17e-04 | 41 | 80 | 3 | PS50014 | |
| Domain | BROMO | 7.70e-04 | 42 | 80 | 3 | SM00297 | |
| Domain | Bromodomain | 7.70e-04 | 42 | 80 | 3 | IPR001487 | |
| Domain | - | 7.70e-04 | 42 | 80 | 3 | 1.20.920.10 | |
| Domain | R3H | 9.72e-04 | 11 | 80 | 2 | PS51061 | |
| Domain | R3H | 9.72e-04 | 11 | 80 | 2 | PF01424 | |
| Domain | - | 9.72e-04 | 11 | 80 | 2 | 3.30.1370.50 | |
| Domain | R3H_dom | 9.72e-04 | 11 | 80 | 2 | IPR001374 | |
| Domain | Oxysterol-bd | 1.16e-03 | 12 | 80 | 2 | IPR000648 | |
| Domain | Oxysterol-bd_CS | 1.16e-03 | 12 | 80 | 2 | IPR018494 | |
| Domain | Oxysterol_BP | 1.16e-03 | 12 | 80 | 2 | PF01237 | |
| Domain | OSBP | 1.16e-03 | 12 | 80 | 2 | PS01013 | |
| Domain | Cadherin_CS | 1.23e-03 | 109 | 80 | 4 | IPR020894 | |
| Domain | CADHERIN_1 | 1.41e-03 | 113 | 80 | 4 | PS00232 | |
| Domain | Cadherin | 1.41e-03 | 113 | 80 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 1.46e-03 | 114 | 80 | 4 | PS50268 | |
| Domain | - | 1.46e-03 | 114 | 80 | 4 | 2.60.40.60 | |
| Domain | CA | 1.50e-03 | 115 | 80 | 4 | SM00112 | |
| Domain | Cadherin-like | 1.55e-03 | 116 | 80 | 4 | IPR015919 | |
| Domain | Cadherin | 1.65e-03 | 118 | 80 | 4 | IPR002126 | |
| Domain | - | 1.83e-03 | 15 | 80 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.83e-03 | 15 | 80 | 2 | SM00501 | |
| Domain | ARID_dom | 1.83e-03 | 15 | 80 | 2 | IPR001606 | |
| Domain | ARID | 1.83e-03 | 15 | 80 | 2 | PS51011 | |
| Domain | ARID | 1.83e-03 | 15 | 80 | 2 | PF01388 | |
| Domain | ZZ | 2.65e-03 | 18 | 80 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.65e-03 | 18 | 80 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.65e-03 | 18 | 80 | 2 | PS01357 | |
| Domain | Cadherin_2 | 2.73e-03 | 65 | 80 | 3 | PF08266 | |
| Domain | Cadherin_N | 2.73e-03 | 65 | 80 | 3 | IPR013164 | |
| Domain | Znf_ZZ | 2.96e-03 | 19 | 80 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.96e-03 | 19 | 80 | 2 | SM00291 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 7.94e-09 | 65 | 58 | 7 | M39682 | |
| Pathway | REACTOME_RORA_ACTIVATES_GENE_EXPRESSION | 7.56e-07 | 18 | 58 | 4 | M26942 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.58e-06 | 24 | 58 | 4 | M13404 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.65e-06 | 8 | 58 | 3 | M22058 | |
| Pathway | REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION | 3.65e-06 | 8 | 58 | 3 | M48024 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 5.79e-06 | 63 | 58 | 5 | MM15613 | |
| Pathway | PID_RETINOIC_ACID_PATHWAY | 6.53e-06 | 30 | 58 | 4 | M207 | |
| Pathway | PID_HIF1_TFPATHWAY | 7.30e-06 | 66 | 58 | 5 | M255 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 9.66e-06 | 33 | 58 | 4 | M5967 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS | 9.66e-06 | 33 | 58 | 4 | MM14737 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 1.07e-05 | 11 | 58 | 3 | M48021 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 1.42e-05 | 12 | 58 | 3 | M27765 | |
| Pathway | PID_SMAD2_3NUCLEAR_PATHWAY | 2.12e-05 | 82 | 58 | 5 | M2 | |
| Pathway | PID_REG_GR_PATHWAY | 2.12e-05 | 82 | 58 | 5 | M115 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 2.33e-05 | 14 | 58 | 3 | M27808 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 2.57e-05 | 42 | 58 | 4 | M48237 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 3.10e-05 | 44 | 58 | 4 | M499 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 3.10e-05 | 44 | 58 | 4 | M27295 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 3.24e-05 | 149 | 58 | 6 | M27888 | |
| Pathway | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | 3.39e-05 | 45 | 58 | 4 | MM14751 | |
| Pathway | WP_ANDROGEN_RECEPTOR_SIGNALING | 3.51e-05 | 91 | 58 | 5 | M39700 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS | 3.56e-05 | 16 | 58 | 3 | M27121 | |
| Pathway | REACTOME_METABOLISM_OF_STEROIDS | 3.91e-05 | 154 | 58 | 6 | M27832 | |
| Pathway | PID_HES_HEY_PATHWAY | 4.39e-05 | 48 | 58 | 4 | M288 | |
| Pathway | REACTOME_HEME_SIGNALING | 4.76e-05 | 49 | 58 | 4 | M41832 | |
| Pathway | BIOCARTA_TGFB_PATHWAY | 6.11e-05 | 19 | 58 | 3 | M18933 | |
| Pathway | PID_AR_TF_PATHWAY | 6.50e-05 | 53 | 58 | 4 | M151 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.17e-05 | 20 | 58 | 3 | M27881 | |
| Pathway | REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF | 7.52e-05 | 55 | 58 | 4 | M27001 | |
| Pathway | REACTOME_CD209_DC_SIGN_SIGNALING | 8.34e-05 | 21 | 58 | 3 | M27485 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 9.63e-05 | 22 | 58 | 3 | MM1370 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.20e-04 | 272 | 58 | 7 | M29619 | |
| Pathway | REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA | 1.21e-04 | 118 | 58 | 5 | M27316 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 1.43e-04 | 25 | 58 | 3 | M11184 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.43e-04 | 25 | 58 | 3 | M27880 | |
| Pathway | BIOCARTA_CARM_ER_PATHWAY | 1.61e-04 | 26 | 58 | 3 | M2499 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 1.65e-04 | 5 | 58 | 2 | MM1575 | |
| Pathway | REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES | 1.65e-04 | 5 | 58 | 2 | M48020 | |
| Pathway | REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES | 1.65e-04 | 5 | 58 | 2 | M48023 | |
| Pathway | REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION | 1.65e-04 | 5 | 58 | 2 | M27228 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.65e-04 | 5 | 58 | 2 | MM14733 | |
| Pathway | REACTOME_ENDOGENOUS_STEROLS | 1.80e-04 | 27 | 58 | 3 | MM14844 | |
| Pathway | REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION | 1.80e-04 | 27 | 58 | 3 | M26943 | |
| Pathway | REACTOME_CIRCADIAN_CLOCK | 1.93e-04 | 70 | 58 | 4 | M938 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.13e-04 | 133 | 58 | 5 | MM15529 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS | 2.16e-04 | 210 | 58 | 6 | M41836 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.44e-04 | 137 | 58 | 5 | M48232 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 2.47e-04 | 6 | 58 | 2 | MM1584 | |
| Pathway | BIOCARTA_PELP1_PATHWAY | 2.47e-04 | 6 | 58 | 2 | M22062 | |
| Pathway | BIOCARTA_NOTCH_PATHWAY | 2.47e-04 | 6 | 58 | 2 | M22074 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 2.74e-04 | 31 | 58 | 3 | M39522 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | 2.78e-04 | 220 | 58 | 6 | M27794 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 2.88e-04 | 142 | 58 | 5 | M27233 | |
| Pathway | BIOCARTA_PPARG_PATHWAY | 3.45e-04 | 7 | 58 | 2 | MM1573 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.45e-04 | 7 | 58 | 2 | MM14734 | |
| Pathway | BIOCARTA_RARRXR_PATHWAY | 3.45e-04 | 7 | 58 | 2 | M6907 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION | 3.90e-04 | 84 | 58 | 4 | M1008 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 4.26e-04 | 86 | 58 | 4 | M2642 | |
| Pathway | REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES | 4.58e-04 | 8 | 58 | 2 | M48022 | |
| Pathway | REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES | 4.58e-04 | 8 | 58 | 2 | M46443 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 4.65e-04 | 37 | 58 | 3 | M27797 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS | 5.03e-04 | 38 | 58 | 3 | M27757 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 5.44e-04 | 39 | 58 | 3 | MM14604 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY | 5.88e-04 | 9 | 58 | 2 | M47451 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 6.22e-04 | 95 | 58 | 4 | M48268 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 6.77e-04 | 42 | 58 | 3 | M17541 | |
| Pathway | REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP | 6.77e-04 | 42 | 58 | 3 | M27172 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 7.33e-04 | 10 | 58 | 2 | MM1532 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 7.33e-04 | 10 | 58 | 2 | MM15535 | |
| Pathway | REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION | 7.33e-04 | 10 | 58 | 2 | M27945 | |
| Pathway | WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873 | 8.30e-04 | 45 | 58 | 3 | M39615 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 8.85e-04 | 46 | 58 | 3 | MM14935 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 8.93e-04 | 11 | 58 | 2 | MM1521 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 8.93e-04 | 11 | 58 | 2 | M5576 | |
| Pathway | REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR | 8.93e-04 | 11 | 58 | 2 | M26924 | |
| Pathway | REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS | 8.93e-04 | 11 | 58 | 2 | MM15510 | |
| Pathway | BIOCARTA_PLCE_PATHWAY | 8.93e-04 | 11 | 58 | 2 | MM1455 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY | 8.93e-04 | 11 | 58 | 2 | M47503 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 9.42e-04 | 47 | 58 | 3 | M7946 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.00e-03 | 48 | 58 | 3 | M611 | |
| Pathway | REACTOME_SUMOYLATION | 1.06e-03 | 189 | 58 | 5 | M27214 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 1.06e-03 | 49 | 58 | 3 | M618 | |
| Pathway | BIOCARTA_CARM1_PATHWAY | 1.07e-03 | 12 | 58 | 2 | M7968 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 1.07e-03 | 12 | 58 | 2 | M22006 | |
| Pathway | REACTOME_ADIPOGENESIS | 1.08e-03 | 110 | 58 | 4 | M48259 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.11e-03 | 191 | 58 | 5 | MM15586 | |
| Pathway | REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING | 1.26e-03 | 13 | 58 | 2 | MM15622 | |
| Pathway | BIOCARTA_PPARA_PATHWAY | 1.27e-03 | 52 | 58 | 3 | M2404 | |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | 1.32e-03 | 296 | 58 | 6 | M27869 | |
| Pathway | WP_TGFBETA_SIGNALING_PATHWAY | 1.34e-03 | 53 | 58 | 3 | MM15880 | |
| Pathway | WP_CIRCADIAN_RHYTHM_GENES | 1.39e-03 | 201 | 58 | 5 | M39605 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 1.44e-03 | 119 | 58 | 4 | M607 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.47e-03 | 14 | 58 | 2 | M27074 | |
| Pathway | REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL | 1.47e-03 | 14 | 58 | 2 | MM14748 | |
| Pathway | WP_TGFBETA_RECEPTOR_SIGNALING | 1.49e-03 | 55 | 58 | 3 | M39351 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS | 1.49e-03 | 55 | 58 | 3 | M27145 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.69e-03 | 15 | 58 | 2 | MM1339 | |
| Pathway | BIOCARTA_RELA_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M10183 | |
| Pathway | BIOCARTA_PITX2_PATHWAY | 1.69e-03 | 15 | 58 | 2 | MM1439 | |
| Pathway | PID_ERB_GENOMIC_PATHWAY | 1.69e-03 | 15 | 58 | 2 | M119 | |
| Pubmed | NCOA2 XRN2 ARID1B ATXN2 GLI2 SEC24A RC3H1 SS18L1 NCOA1 CHD8 CHD7 ZMIZ1 RAD54L2 R3HDM1 ARID1A LARP4 TAF1L ERBIN CREBBP SOX13 JMJD1C EP300 RAI2 HEXIM2 TBP | 1.96e-15 | 1429 | 83 | 25 | 35140242 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | NCOA2 ARID1B SS18L1 NCOA1 CHD8 CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP SOX13 EP300 | 4.72e-11 | 351 | 83 | 12 | 38297188 |
| Pubmed | 1.14e-10 | 152 | 83 | 9 | 38360978 | ||
| Pubmed | Temporal/spatial expression of nuclear receptor coactivators in the mouse lung. | 4.51e-10 | 6 | 83 | 4 | 11076796 | |
| Pubmed | Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. | 1.05e-09 | 7 | 83 | 4 | 9590696 | |
| Pubmed | 1.05e-09 | 7 | 83 | 4 | 15641800 | ||
| Pubmed | 1.35e-09 | 21 | 83 | 5 | 19596656 | ||
| Pubmed | 4.27e-09 | 157 | 83 | 8 | 30186101 | ||
| Pubmed | 5.06e-09 | 57 | 83 | 6 | 18022353 | ||
| Pubmed | 9.82e-09 | 11 | 83 | 4 | 10454579 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | NCOA2 ARID1B ATXN2 SEC24A RC3H1 ZMIZ1 ARID1A LARP4 CREBBP JMJD1C EP300 | 1.23e-08 | 457 | 83 | 11 | 32344865 |
| Pubmed | 1.31e-08 | 3 | 83 | 3 | 11713256 | ||
| Pubmed | Dendrite development regulated by CREST, a calcium-regulated transcriptional activator. | 1.31e-08 | 3 | 83 | 3 | 14716005 | |
| Pubmed | 1.67e-08 | 268 | 83 | 9 | 33640491 | ||
| Pubmed | Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres. | 2.96e-08 | 14 | 83 | 4 | 11500849 | |
| Pubmed | 3.44e-08 | 78 | 83 | 6 | 28611094 | ||
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | NCOA2 ARID1B NCOA1 BICRAL CHD7 ARID1A CREBBP JMJD1C EP300 RAI2 | 3.98e-08 | 398 | 83 | 10 | 35016035 |
| Pubmed | 4.03e-08 | 15 | 83 | 4 | 23785148 | ||
| Pubmed | NCOA2 XRN2 ARID1B ATXN2 U2SURP NCOA1 CHD8 BICRAL CHD7 RAD54L2 RRM1 ARID1A CREBBP JMJD1C EP300 | 4.87e-08 | 1103 | 83 | 15 | 34189442 | |
| Pubmed | 5.01e-08 | 83 | 83 | 6 | 28794006 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 8995708 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 16613851 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 12208951 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 11463834 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 12024042 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 11113179 | ||
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 17697320 | ||
| Pubmed | A simple method to screen ligands of peroxisome proliferator-activated receptor delta. | 5.23e-08 | 4 | 83 | 3 | 16930961 | |
| Pubmed | 5.23e-08 | 4 | 83 | 3 | 15449938 | ||
| Pubmed | 7.01e-08 | 17 | 83 | 4 | 19183483 | ||
| Pubmed | Human p300 protein is a coactivator for the transcription factor MyoD. | 1.31e-07 | 5 | 83 | 3 | 8621548 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 12714702 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 14722092 | ||
| Pubmed | SRC-1 and GRIP1 coactivate transcription with hepatocyte nuclear factor 4. | 1.31e-07 | 5 | 83 | 3 | 9812974 | |
| Pubmed | MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function. | 1.31e-07 | 5 | 83 | 3 | 15657427 | |
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 10722728 | ||
| Pubmed | 1.42e-07 | 20 | 83 | 4 | 11877444 | ||
| Pubmed | 2.32e-07 | 263 | 83 | 8 | 34702444 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 10327051 | ||
| Pubmed | DYRK1A interacts with histone acetyl transferase p300 and CBP and localizes to enhancers. | 2.61e-07 | 6 | 83 | 3 | 30137413 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 16923966 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 10497212 | ||
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 15731352 | ||
| Pubmed | Role of CBP in regulating HIF-1-mediated activation of transcription. | 2.61e-07 | 6 | 83 | 3 | 15615775 | |
| Pubmed | 2.61e-07 | 6 | 83 | 3 | 10973497 | ||
| Pubmed | BRCA1-IRIS regulates cyclin D1 expression in breast cancer cells. | 4.56e-07 | 7 | 83 | 3 | 16860316 | |
| Pubmed | The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. | 4.56e-07 | 7 | 83 | 3 | 9192892 | |
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 12709428 | ||
| Pubmed | 5.91e-07 | 28 | 83 | 4 | 24880616 | ||
| Pubmed | Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by I kappa B kinase. | 7.28e-07 | 8 | 83 | 3 | 11971985 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 12082103 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 17475621 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 10490106 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 11744733 | ||
| Pubmed | BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors. | 8.65e-07 | 134 | 83 | 6 | 25452129 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 1.02e-06 | 220 | 83 | 7 | 35785414 | |
| Pubmed | The murine G+C-rich promoter binding protein mGPBP is required for promoter-specific transcription. | 1.09e-06 | 9 | 83 | 3 | 14612417 | |
| Pubmed | Natural helix 9 mutants of PPARγ differently affect its transcriptional activity. | 1.55e-06 | 10 | 83 | 3 | 30595551 | |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 17363140 | ||
| Pubmed | NPPA ATXN2 KAT6A RAD54L2 R3HDM1 C1orf94 NOTCH1 PCDH17 RAI2 TBP | 1.92e-06 | 608 | 83 | 10 | 16713569 | |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 36613751 | ||
| Pubmed | Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes. | 2.13e-06 | 11 | 83 | 3 | 15681609 | |
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 18003620 | ||
| Pubmed | 2.33e-06 | 39 | 83 | 4 | 25859222 | ||
| Pubmed | USP36 ARID1B TRAFD1 SS18L1 KAT6A GPT AHR CHD8 BICRAL ARID1A CREBBP EP300 TBP | 2.35e-06 | 1116 | 83 | 13 | 31753913 | |
| Pubmed | Identification and Functional Characterization of a Novel Androgen Receptor Coregulator, EAP1. | 2.58e-06 | 40 | 83 | 4 | 34585037 | |
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 12189208 | ||
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 21402781 | ||
| Pubmed | Requirement of tissue-selective TBP-associated factor TAFII105 in ovarian development. | 3.68e-06 | 13 | 83 | 3 | 11557891 | |
| Pubmed | 3.68e-06 | 13 | 83 | 3 | 11266503 | ||
| Pubmed | Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome. | 4.68e-06 | 14 | 83 | 3 | 36289231 | |
| Pubmed | E protein silencing by the leukemogenic AML1-ETO fusion protein. | 4.68e-06 | 14 | 83 | 3 | 15333839 | |
| Pubmed | MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. | 4.68e-06 | 14 | 83 | 3 | 17641689 | |
| Pubmed | 4.68e-06 | 14 | 83 | 3 | 12482968 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 27881875 | ||
| Pubmed | New types of MYST3-CBP and CBP-MYST3 fusion transcripts in t(8;16)(p11;p13) acute myeloid leukemias. | 5.63e-06 | 2 | 83 | 2 | 17296583 | |
| Pubmed | Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia. | 5.63e-06 | 2 | 83 | 2 | 34845315 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19729597 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11279184 | ||
| Pubmed | Expression of the MOZ-TIF2 oncoprotein in mice represses senescence. | 5.63e-06 | 2 | 83 | 2 | 26854485 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 39287984 | ||
| Pubmed | SRC-1 and TIF2 control energy balance between white and brown adipose tissues. | 5.63e-06 | 2 | 83 | 2 | 12507421 | |
| Pubmed | Lifelong restructuring of 3D genome architecture in cerebellar granule cells. | 5.63e-06 | 2 | 83 | 2 | 37676945 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20717166 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25893291 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11559821 | ||
| Pubmed | CHD8 interacts with CHD7, a protein which is mutated in CHARGE syndrome. | 5.63e-06 | 2 | 83 | 2 | 20453063 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32576962 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 19822209 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16864582 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24522976 | ||
| Pubmed | CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. | 5.63e-06 | 2 | 83 | 2 | 21847097 | |
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 5.63e-06 | 2 | 83 | 2 | 37611161 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 32791957 | ||
| Pubmed | p300 or CBP is required for insulin-stimulated glucose uptake in skeletal muscle and adipocytes. | 5.63e-06 | 2 | 83 | 2 | 34813504 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33237915 | ||
| Pubmed | The Notch1 receptor is cleaved constitutively by a furin-like convertase. | 5.63e-06 | 2 | 83 | 2 | 9653148 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 20301699 | ||
| Pubmed | Partially redundant functions of SRC-1 and TIF2 in postnatal survival and male reproduction. | 5.63e-06 | 2 | 83 | 2 | 15070739 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24639469 | ||
| Interaction | HNF4A interactions | NCOA2 NPPA ARID1B MECR SS18L1 NCOA1 CHD7 RAD54L2 ARID1A CREBBP EP300 TBP | 1.00e-09 | 275 | 81 | 12 | int:HNF4A |
| Interaction | SOX7 interactions | 1.34e-09 | 82 | 81 | 8 | int:SOX7 | |
| Interaction | SMAD3 interactions | ARID1B ZFYVE9 FOXL2 FURIN SS18L1 KAT6A NCOA1 CHD8 ZMIZ1 ARID1A ERBIN CREBBP EP300 NOTCH1 | 2.68e-09 | 447 | 81 | 14 | int:SMAD3 |
| Interaction | ALG13 interactions | USP36 NCOA2 ARID1B TIA1 ATXN2 RC3H1 R3HDM1 ARID1A JMJD1C EP300 | 3.20e-09 | 183 | 81 | 10 | int:ALG13 |
| Interaction | SMG7 interactions | NCOA2 XRN2 ARID1B ATXN2 AMOT RC3H1 NCOA1 CHD8 R3HDM1 ARID1A CREBBP JMJD1C | 5.36e-09 | 319 | 81 | 12 | int:SMG7 |
| Interaction | CRX interactions | NCOA2 ARID1B ABI2 SS18L1 NCOA1 CHD7 ZMIZ1 ARID1A LARP4 CREBBP EP300 | 5.72e-09 | 254 | 81 | 11 | int:CRX |
| Interaction | NUP35 interactions | NCOA2 ARID1B ATXN2 NKX2-1 SEC24A RC3H1 FURIN ZMIZ1 ARID1A LARP4 CREBBP JMJD1C EP300 | 1.35e-08 | 424 | 81 | 13 | int:NUP35 |
| Interaction | PAX8 interactions | 1.51e-08 | 111 | 81 | 8 | int:PAX8 | |
| Interaction | EGR2 interactions | 2.85e-08 | 171 | 81 | 9 | int:EGR2 | |
| Interaction | ETS1 interactions | 2.98e-08 | 121 | 81 | 8 | int:ETS1 | |
| Interaction | TLE3 interactions | NCOA2 ARID1B GLI2 SEC24A NCOA1 ZMIZ1 STAM RAD54L2 ARID1A CREBBP EP300 NOTCH1 | 3.32e-08 | 376 | 81 | 12 | int:TLE3 |
| Interaction | SMARCA4 interactions | USP36 ARID1B NKX2-1 SS18L1 KAT6A AHR NCOA1 BICRAL CHD7 ARID1A CREBBP EP300 NOTCH1 | 3.71e-08 | 462 | 81 | 13 | int:SMARCA4 |
| Interaction | FEV interactions | 1.25e-07 | 203 | 81 | 9 | int:FEV | |
| Interaction | NCOA1 interactions | 1.29e-07 | 146 | 81 | 8 | int:NCOA1 | |
| Interaction | SS18L1 interactions | 1.34e-07 | 98 | 81 | 7 | int:SS18L1 | |
| Interaction | ERG interactions | 2.77e-07 | 223 | 81 | 9 | int:ERG | |
| Interaction | ETV4 interactions | 3.42e-07 | 69 | 81 | 6 | int:ETV4 | |
| Interaction | SP7 interactions | NCOA2 XRN2 ARID1B SS18L1 NCOA1 CHD7 ZMIZ1 ARID1A CREBBP EP300 | 3.84e-07 | 304 | 81 | 10 | int:SP7 |
| Interaction | RXRA interactions | 3.96e-07 | 169 | 81 | 8 | int:RXRA | |
| Interaction | TBXT interactions | 4.27e-07 | 116 | 81 | 7 | int:TBXT | |
| Interaction | TEAD1 interactions | 5.39e-07 | 176 | 81 | 8 | int:TEAD1 | |
| Interaction | EYA4 interactions | 5.70e-07 | 243 | 81 | 9 | int:EYA4 | |
| Interaction | EGLN3 interactions | NCOA2 AMER1 TRAFD1 ZFYVE9 ATXN2 ABI2 AMOT GLI2 SEC24A SIK2 AHR MAP7D2 CHD8 RAD54L2 R3HDM1 RRM1 ERBIN CREBBP JMJD1C | 6.56e-07 | 1296 | 81 | 19 | int:EGLN3 |
| Interaction | WWTR1 interactions | NCOA2 ARID1B NKX2-1 AMOT CHD8 ARID1A ERBIN CREBBP JMJD1C EP300 NOTCH1 | 9.69e-07 | 422 | 81 | 11 | int:WWTR1 |
| Interaction | IRF1 interactions | 1.03e-06 | 83 | 81 | 6 | int:IRF1 | |
| Interaction | AR interactions | NCOA2 XRN2 ARID1B GLI2 U2SURP AHR NCOA1 CHD8 CHD7 ZMIZ1 RAD54L2 ARID1A CREBBP JMJD1C EP300 TBP | 1.73e-06 | 992 | 81 | 16 | int:AR |
| Interaction | EP300 interactions | NCOA2 NUTM1 XRN2 AMOT SEC24A U2SURP SS18L1 KAT6A SIK2 AHR NCOA1 CITED1 RRM1 ARID1A LARP4 CREBBP EP300 NOTCH1 TBP | 2.11e-06 | 1401 | 81 | 19 | int:EP300 |
| Interaction | TPRX2 interactions | 3.01e-06 | 56 | 81 | 5 | int:TPRX2 | |
| Interaction | NCOA3 interactions | 3.29e-06 | 224 | 81 | 8 | int:NCOA3 | |
| Interaction | TBR1 interactions | 6.27e-06 | 113 | 81 | 6 | int:TBR1 | |
| Interaction | TLX1 interactions | 6.69e-06 | 175 | 81 | 7 | int:TLX1 | |
| Interaction | PBRM1 interactions | 9.29e-06 | 258 | 81 | 8 | int:PBRM1 | |
| Interaction | LHX3 interactions | 9.62e-06 | 185 | 81 | 7 | int:LHX3 | |
| Interaction | PAX7 interactions | 1.07e-05 | 124 | 81 | 6 | int:PAX7 | |
| Interaction | SMAP2 interactions | 1.11e-05 | 189 | 81 | 7 | int:SMAP2 | |
| Interaction | HNF1B interactions | 1.14e-05 | 190 | 81 | 7 | int:HNF1B | |
| Interaction | E2F5 interactions | 1.29e-05 | 36 | 81 | 4 | int:E2F5 | |
| Interaction | HOXB2 interactions | 1.29e-05 | 36 | 81 | 4 | int:HOXB2 | |
| Interaction | MYOD1 interactions | 1.31e-05 | 194 | 81 | 7 | int:MYOD1 | |
| Interaction | KLF5 interactions | 1.35e-05 | 195 | 81 | 7 | int:KLF5 | |
| Interaction | ARID1A interactions | 1.52e-05 | 276 | 81 | 8 | int:ARID1A | |
| Interaction | RORA interactions | 1.79e-05 | 39 | 81 | 4 | int:RORA | |
| Interaction | NR5A2 interactions | 2.19e-05 | 41 | 81 | 4 | int:NR5A2 | |
| Interaction | NCOA2 interactions | 2.22e-05 | 141 | 81 | 6 | int:NCOA2 | |
| Interaction | SMARCC1 interactions | 2.35e-05 | 384 | 81 | 9 | int:SMARCC1 | |
| Interaction | MKRN2 interactions | 2.39e-05 | 385 | 81 | 9 | int:MKRN2 | |
| Interaction | STAT6 interactions | 2.64e-05 | 87 | 81 | 5 | int:STAT6 | |
| Interaction | CREBBP interactions | NCOA2 ARID1B NKX2-1 SS18L1 KAT6A NCOA1 CITED1 ARID1A CREBBP EP300 TBP | 2.68e-05 | 599 | 81 | 11 | int:CREBBP |
| Interaction | RARA interactions | 3.21e-05 | 223 | 81 | 7 | int:RARA | |
| Interaction | PPARG interactions | 3.25e-05 | 307 | 81 | 8 | int:PPARG | |
| Interaction | SOX10 interactions | 3.46e-05 | 92 | 81 | 5 | int:SOX10 | |
| Interaction | RARB interactions | 3.48e-05 | 46 | 81 | 4 | int:RARB | |
| Interaction | FOS interactions | 3.64e-05 | 312 | 81 | 8 | int:FOS | |
| Interaction | BAG2 interactions | USP36 NCOA2 AMOT RC3H1 SIK2 STAM R3HDM1 DNAJC6 ERBIN CREBBP EP300 | 3.79e-05 | 622 | 81 | 11 | int:BAG2 |
| Interaction | DPF3 interactions | 4.04e-05 | 95 | 81 | 5 | int:DPF3 | |
| Interaction | PIAS3 interactions | 4.04e-05 | 95 | 81 | 5 | int:PIAS3 | |
| Interaction | MAML2 interactions | 4.08e-05 | 17 | 81 | 3 | int:MAML2 | |
| Interaction | SIRT6 interactions | XRN2 ARID1B AMOT AHR SMG9 MAP7D2 CHD8 ARID1A LARP4 CREBBP EP300 | 4.13e-05 | 628 | 81 | 11 | int:SIRT6 |
| Interaction | SOX9 interactions | 4.47e-05 | 97 | 81 | 5 | int:SOX9 | |
| Interaction | CTNNB1 interactions | USP36 NCOA2 AMER1 ZFYVE9 TIA1 AMOT AHR CHD8 CITED1 ZMIZ1 ERBIN CREBBP EP300 NOTCH1 | 4.49e-05 | 1009 | 81 | 14 | int:CTNNB1 |
| Interaction | RUNX1 interactions | 4.75e-05 | 324 | 81 | 8 | int:RUNX1 | |
| Interaction | RNF43 interactions | 5.36e-05 | 427 | 81 | 9 | int:RNF43 | |
| Interaction | LHX4 interactions | 5.56e-05 | 166 | 81 | 6 | int:LHX4 | |
| Interaction | SPIB interactions | 6.79e-05 | 20 | 81 | 3 | int:SPIB | |
| Interaction | CIITA interactions | 7.07e-05 | 55 | 81 | 4 | int:CIITA | |
| Interaction | TBP interactions | 7.13e-05 | 253 | 81 | 7 | int:TBP | |
| Interaction | RBPJ interactions | 7.31e-05 | 254 | 81 | 7 | int:RBPJ | |
| Interaction | BCL3 interactions | 7.59e-05 | 56 | 81 | 4 | int:BCL3 | |
| Interaction | KLF13 interactions | 7.90e-05 | 21 | 81 | 3 | int:KLF13 | |
| Interaction | THRA interactions | 8.50e-05 | 111 | 81 | 5 | int:THRA | |
| Interaction | NR5A1 interactions | 9.95e-05 | 60 | 81 | 4 | int:NR5A1 | |
| Interaction | PRKAA1 interactions | 1.02e-04 | 268 | 81 | 7 | int:PRKAA1 | |
| Interaction | THRB interactions | 1.04e-04 | 186 | 81 | 6 | int:THRB | |
| Interaction | CITED2 interactions | 1.05e-04 | 23 | 81 | 3 | int:CITED2 | |
| Interaction | ETS2 interactions | 1.06e-04 | 61 | 81 | 4 | int:ETS2 | |
| Interaction | PAX6 interactions | 1.11e-04 | 366 | 81 | 8 | int:PAX6 | |
| Interaction | CEBPA interactions | NCOA2 XRN2 ARID1B ATXN2 U2SURP NCOA1 CHD8 BICRAL CHD7 RAD54L2 RRM1 ARID1A CREBBP JMJD1C EP300 | 1.15e-04 | 1245 | 81 | 15 | int:CEBPA |
| Interaction | NTN5 interactions | 1.19e-04 | 24 | 81 | 3 | int:NTN5 | |
| Interaction | NR6A1 interactions | 1.19e-04 | 24 | 81 | 3 | int:NR6A1 | |
| Interaction | PAX5 interactions | 1.28e-04 | 64 | 81 | 4 | int:PAX5 | |
| Interaction | HOXB7 interactions | 1.52e-04 | 26 | 81 | 3 | int:HOXB7 | |
| Interaction | SPI1 interactions | 1.53e-04 | 67 | 81 | 4 | int:SPI1 | |
| Interaction | MRTO4 interactions | 1.55e-04 | 200 | 81 | 6 | int:MRTO4 | |
| Interaction | SMARCE1 interactions | 1.56e-04 | 287 | 81 | 7 | int:SMARCE1 | |
| Interaction | GCM1 interactions | 1.62e-04 | 68 | 81 | 4 | int:GCM1 | |
| Interaction | KLF15 interactions | 1.66e-04 | 290 | 81 | 7 | int:KLF15 | |
| Interaction | R3HDM2 interactions | 1.73e-04 | 129 | 81 | 5 | int:R3HDM2 | |
| Interaction | PAX9 interactions | 1.79e-04 | 130 | 81 | 5 | int:PAX9 | |
| Interaction | AHR interactions | 1.92e-04 | 132 | 81 | 5 | int:AHR | |
| Interaction | ZFR interactions | 2.09e-04 | 301 | 81 | 7 | int:ZFR | |
| Interaction | MAML1 interactions | 2.13e-04 | 73 | 81 | 4 | int:MAML1 | |
| Interaction | GFI1B interactions | 2.21e-04 | 136 | 81 | 5 | int:GFI1B | |
| Interaction | NAF1 interactions | 2.36e-04 | 138 | 81 | 5 | int:NAF1 | |
| Interaction | ATXN1 interactions | ATXN2 U2SURP KAT6A BICRAL CITED1 RAD54L2 R3HDM1 ARID1A LARP4 CREBBP C1orf94 JMJD1C RAI2 | 2.42e-04 | 1039 | 81 | 13 | int:ATXN1 |
| Interaction | SS18L2 interactions | 2.49e-04 | 76 | 81 | 4 | int:SS18L2 | |
| Interaction | FAM168A interactions | 2.70e-04 | 142 | 81 | 5 | int:FAM168A | |
| Interaction | FMR1 interactions | 2.97e-04 | 536 | 81 | 9 | int:FMR1 | |
| Interaction | NCOA6 interactions | 2.97e-04 | 145 | 81 | 5 | int:NCOA6 | |
| Interaction | CPEB1 interactions | 3.07e-04 | 146 | 81 | 5 | int:CPEB1 | |
| Interaction | ELF5 interactions | 3.17e-04 | 147 | 81 | 5 | int:ELF5 | |
| Cytoband | 20q13.3 | 6.01e-04 | 20 | 83 | 2 | 20q13.3 | |
| Cytoband | Xp22.11 | 6.63e-04 | 21 | 83 | 2 | Xp22.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrXp22 | 1.13e-03 | 250 | 83 | 4 | chrXp22 | |
| Cytoband | 1p35.3 | 1.74e-03 | 34 | 83 | 2 | 1p35.3 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 5.76e-10 | 17 | 47 | 5 | 486 | |
| GeneFamily | Oxysterol binding proteins|Pleckstrin homology domain containing | 4.29e-04 | 12 | 47 | 2 | 670 | |
| GeneFamily | AT-rich interaction domain containing | 6.80e-04 | 15 | 47 | 2 | 418 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.85e-04 | 18 | 47 | 2 | 91 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.92e-03 | 110 | 47 | 3 | 420 | |
| GeneFamily | Zinc fingers CCCH-type | 3.73e-03 | 35 | 47 | 2 | 73 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NCOA2 ZFYVE9 TIA1 ATXN2 INHBB SEC24A U2SURP KAT6A NCOA1 BICRAL ZMIZ1 STAM R3HDM1 LARP4 CREBBP PLCE1 | 9.75e-09 | 856 | 83 | 16 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZFYVE9 ATXN2 SEC24A U2SURP KAT6A NCOA1 ZMIZ1 STAM R3HDM1 LARP4 CREBBP | 2.55e-07 | 466 | 83 | 11 | M13522 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | USP36 OSBPL2 SEC24A AHR NCOA1 ZMIZ1 STAM LARP4 CREBBP JMJD1C EP300 NOTCH1 | 1.05e-05 | 822 | 83 | 12 | M6782 |
| Coexpression | GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP | 4.12e-05 | 199 | 83 | 6 | M9523 | |
| Coexpression | GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP | 4.12e-05 | 199 | 83 | 6 | M9759 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#2_top-relative-expression-ranked_500 | 2.52e-06 | 107 | 77 | 6 | gudmap_developingGonad_e14.5_ epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.95e-06 | 275 | 77 | 8 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.02e-05 | 230 | 77 | 7 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.22e-05 | 323 | 77 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 7.19e-05 | 281 | 77 | 7 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | PTPDC1 FOXL2 MECR TIA1 INHBB MAP7D2 CHD8 CITED1 R3HDM1 LARP4 JMJD1C | 1.07e-04 | 776 | 77 | 11 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 1.25e-04 | 413 | 77 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | AMER1 RAP2B FOXL2 MECR TIA1 ATXN2 CHD8 ZMIZ1 R3HDM1 CREBBP JMJD1C | 1.25e-04 | 790 | 77 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | AMER1 RAP2B FOXL2 MECR TIA1 ATXN2 CHD8 STAM R3HDM1 CREBBP JMJD1C | 1.39e-04 | 799 | 77 | 11 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000 | AMER1 MECR TIA1 ATXN2 INHBB CHD8 R3HDM1 ARID1A LARP4 CREBBP JMJD1C | 1.46e-04 | 804 | 77 | 11 | gudmap_developingGonad_e12.5_ovary_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | AMER1 RAP2B MECR TIA1 CHD8 CHD7 R3HDM1 ARID1A LARP4 CREBBP JMJD1C | 1.65e-04 | 815 | 77 | 11 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | TBX22 PTPDC1 SYNPO2 AMER1 ARPP21 AHR NCOA1 MAP7D2 CITED1 CHD7 ZMIZ1 PCDH17 | 1.78e-04 | 967 | 77 | 12 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 2.16e-04 | 150 | 77 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 2.97e-04 | 595 | 77 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#3_top-relative-expression-ranked_500 | 3.26e-04 | 37 | 77 | 3 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.57e-04 | 259 | 77 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| ToppCell | E18.5-samps-Endothelial-Mature_fetal_endothelial-endothelial_cells_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.36e-05 | 163 | 83 | 5 | d6f9b7280c44d120df5a72dfc2ebb26ffbb5752b | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-05 | 173 | 83 | 5 | 5d7c53c6d1cdd385e44b79b82faec901747d1736 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.86e-05 | 174 | 83 | 5 | 9eab43885496b8586f8ec5b4bcb1fd5b209218e5 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 184 | 83 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 83 | 5 | dec60254204014083ff3b4aec0cc75410950a486 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 83 | 5 | 201465dc0d7aa0336a36d37805cae1155a5adfe1 | |
| ToppCell | facs-Trachea-nan-24m-Endothelial-endothelial_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 185 | 83 | 5 | 334f006c3ef33338ff8d649309d3f448733a3a99 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.56e-05 | 186 | 83 | 5 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | PND07-28-samps-Endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.76e-05 | 189 | 83 | 5 | eb2f8c8a90e5e9f6697a2d13274c94f40e1973e4 | |
| ToppCell | PND07-28-samps-Endothelial-Postnatal_endothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.76e-05 | 189 | 83 | 5 | d4a25d59d88325d3b20f4287e9b1160c82961a96 | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 191 | 83 | 5 | 79b399496bd7322a1d53c43378f48695fd09a5d9 | |
| ToppCell | facs-Trachea-24m-Endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 191 | 83 | 5 | 9c6d5d045781c6506ae80e318427ef1e0d87f45c | |
| ToppCell | facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.90e-05 | 191 | 83 | 5 | 1b1e943709d0c3283a980c7c965ef1f110506a29 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 193 | 83 | 5 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-05 | 194 | 83 | 5 | f159ef8541d75a4e98468947f231bb463bec922c | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.90e-07 | 173 | 81 | 8 | 2881_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.07e-07 | 175 | 81 | 8 | 1014_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.57e-07 | 180 | 81 | 8 | 4821_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 2.57e-07 | 180 | 81 | 8 | 6886_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 2.70e-06 | 172 | 81 | 7 | 1072_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.70e-06 | 172 | 81 | 7 | 2794_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-06 | 174 | 81 | 7 | 5693_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.52e-06 | 179 | 81 | 7 | 6609_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.65e-06 | 180 | 81 | 7 | 3688_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.78e-06 | 181 | 81 | 7 | 6951_DN | |
| Drug | AC1L9M2J | 7.62e-06 | 76 | 81 | 5 | CID000448538 | |
| Drug | AC1L2E0P | 1.37e-05 | 307 | 81 | 8 | CID000019390 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.74e-05 | 165 | 81 | 6 | 6085_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.03e-05 | 168 | 81 | 6 | 3868_DN | |
| Drug | AC1L9FY1 | 3.05e-05 | 101 | 81 | 5 | CID000444218 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.13e-05 | 169 | 81 | 6 | 5231_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.24e-05 | 170 | 81 | 6 | 3791_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.24e-05 | 170 | 81 | 6 | 1050_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.24e-05 | 170 | 81 | 6 | 5417_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.35e-05 | 171 | 81 | 6 | 1000_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 3.35e-05 | 171 | 81 | 6 | 7535_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.35e-05 | 171 | 81 | 6 | 6879_DN | |
| Drug | rutecarpine | 3.41e-05 | 18 | 81 | 3 | ctd:C028632 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.46e-05 | 172 | 81 | 6 | 2330_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.57e-05 | 173 | 81 | 6 | 4665_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.57e-05 | 173 | 81 | 6 | 3243_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.57e-05 | 173 | 81 | 6 | 5987_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.57e-05 | 173 | 81 | 6 | 5950_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.69e-05 | 174 | 81 | 6 | 5065_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.69e-05 | 174 | 81 | 6 | 1659_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.69e-05 | 174 | 81 | 6 | 5580_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.93e-05 | 176 | 81 | 6 | 6784_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 3.93e-05 | 176 | 81 | 6 | 6980_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.93e-05 | 176 | 81 | 6 | 3312_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A | 4.06e-05 | 177 | 81 | 6 | 1645_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.06e-05 | 177 | 81 | 6 | 6434_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 4.06e-05 | 177 | 81 | 6 | 7047_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.06e-05 | 177 | 81 | 6 | 3227_DN | |
| Drug | SAHA; Down 200; 10uM; PC3; HT_HG-U133A | 4.19e-05 | 178 | 81 | 6 | 4444_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.32e-05 | 179 | 81 | 6 | 5822_DN | |
| Drug | scriptaid; Down 200; 10uM; MCF7; HT_HG-U133A | 4.32e-05 | 179 | 81 | 6 | 6901_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.46e-05 | 180 | 81 | 6 | 4541_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 5.35e-05 | 186 | 81 | 6 | 6874_DN | |
| Drug | (+/-)-blebbistatin; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 6.76e-05 | 194 | 81 | 6 | 954_UP | |
| Drug | iclaprim | 7.09e-05 | 62 | 81 | 4 | CID000213043 | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 4443_UP | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 7.16e-05 | 196 | 81 | 6 | 7559_DN | |
| Drug | PeCDF | 7.30e-05 | 23 | 81 | 3 | CID000042128 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 7.36e-05 | 197 | 81 | 6 | 1151_DN | |
| Drug | Bezafibrate [41859-67-0]; Down 200; 11uM; HL60; HT_HG-U133A | 7.57e-05 | 198 | 81 | 6 | 1275_DN | |
| Drug | indole | 7.57e-05 | 198 | 81 | 6 | CID000000798 | |
| Drug | Troleandomycin [2751-09-9]; Down 200; 5uM; HL60; HG-U133A | 7.78e-05 | 199 | 81 | 6 | 1965_DN | |
| Drug | galangin | 1.02e-04 | 68 | 81 | 4 | ctd:C037032 | |
| Drug | Felodipine | 1.06e-04 | 26 | 81 | 3 | ctd:D015736 | |
| Drug | 3,4-dimethoxy-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenylbenzenesulfonamide | 1.24e-04 | 5 | 81 | 2 | ctd:C575894 | |
| Drug | MF101 extract | 1.24e-04 | 5 | 81 | 2 | ctd:C517398 | |
| Drug | anacardic acid | 1.64e-04 | 30 | 81 | 3 | CID000167551 | |
| Drug | butamben | 1.86e-04 | 6 | 81 | 2 | ctd:C004605 | |
| Drug | AC1L1XSE | 1.86e-04 | 6 | 81 | 2 | CID000037467 | |
| Drug | 2',3',4',5'-tetrachloro-4-biphenylol | 1.86e-04 | 6 | 81 | 2 | ctd:C104006 | |
| Drug | silver-sulfide (Ag2S | 2.59e-04 | 7 | 81 | 2 | CID000030686 | |
| Drug | Cyproterone Acetate | 2.62e-04 | 35 | 81 | 3 | ctd:D017373 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.76e-04 | 161 | 81 | 5 | 4768_DN | |
| Drug | baicalin | 2.85e-04 | 36 | 81 | 3 | ctd:C038044 | |
| Drug | anthranilic acid | 2.88e-04 | 89 | 81 | 4 | CID000000227 | |
| Drug | Mitotane | 2.88e-04 | 89 | 81 | 4 | ctd:D008939 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 2.92e-04 | 163 | 81 | 5 | 5594_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-04 | 163 | 81 | 5 | 7453_DN | |
| Drug | Triiodothyronine | 2.95e-04 | 477 | 81 | 8 | ctd:D014284 | |
| Drug | AC1L1COZ | 3.01e-04 | 90 | 81 | 4 | CID000001996 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.09e-04 | 165 | 81 | 5 | 2835_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.09e-04 | 165 | 81 | 5 | 5625_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.18e-04 | 166 | 81 | 5 | 7324_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.18e-04 | 166 | 81 | 5 | 2268_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.45e-04 | 169 | 81 | 5 | 5572_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.45e-04 | 169 | 81 | 5 | 6064_DN | |
| Drug | AC1N0FHX | 3.45e-04 | 8 | 81 | 2 | CID003916227 | |
| Drug | AC1MHU3O | 3.45e-04 | 8 | 81 | 2 | CID003032423 | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.64e-04 | 171 | 81 | 5 | 1234_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.64e-04 | 171 | 81 | 5 | 4954_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.64e-04 | 171 | 81 | 5 | 5441_DN | |
| Drug | AC1ND2OB | 3.67e-04 | 265 | 81 | 6 | CID004568637 | |
| Drug | TCPOBOP | 3.70e-04 | 95 | 81 | 4 | CID000005382 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.74e-04 | 172 | 81 | 5 | 3428_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 3.74e-04 | 172 | 81 | 5 | 6439_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.74e-04 | 172 | 81 | 5 | 5209_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.74e-04 | 172 | 81 | 5 | 6993_DN | |
| Drug | Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.74e-04 | 172 | 81 | 5 | 1637_DN | |
| Drug | AC1L1GHE | 3.85e-04 | 96 | 81 | 4 | CID000003684 | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 3.94e-04 | 174 | 81 | 5 | 7530_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 3.94e-04 | 174 | 81 | 5 | 6579_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.94e-04 | 174 | 81 | 5 | 3462_DN | |
| Drug | HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.94e-04 | 174 | 81 | 5 | 909_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 3.94e-04 | 174 | 81 | 5 | 5745_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.05e-04 | 175 | 81 | 5 | 6736_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 4.05e-04 | 175 | 81 | 5 | 3787_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 4.05e-04 | 175 | 81 | 5 | 7236_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 4.05e-04 | 175 | 81 | 5 | 1058_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.05e-04 | 175 | 81 | 5 | 6891_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 4.16e-04 | 176 | 81 | 5 | 7499_DN | |
| Disease | Adenoid Cystic Carcinoma | 1.28e-08 | 100 | 82 | 7 | C0010606 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 5.19e-06 | 41 | 82 | 4 | C0496956 | |
| Disease | Breast adenocarcinoma | 5.19e-06 | 41 | 82 | 4 | C0858252 | |
| Disease | Acute myeloid leukemia with t(8;16)(p11;p13) translocation | 7.63e-06 | 2 | 82 | 2 | C4511003 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.63e-06 | 2 | 82 | 2 | 180849 | |
| Disease | Rubinstein-Taybi syndrome due to CREBBP mutations | 7.63e-06 | 2 | 82 | 2 | cv:C4551859 | |
| Disease | Menke-Hennekam syndrome | 7.63e-06 | 2 | 82 | 2 | cv:C5681632 | |
| Disease | Rubinstein-Taybi syndrome (implicated_via_orthology) | 7.63e-06 | 2 | 82 | 2 | DOID:1933 (implicated_via_orthology) | |
| Disease | Rubinstein-Taybi syndrome | 7.63e-06 | 2 | 82 | 2 | cv:C0035934 | |
| Disease | RUBINSTEIN-TAYBI SYNDROME 1 | 7.63e-06 | 2 | 82 | 2 | C4551859 | |
| Disease | Rubinstein-Taybi syndrome (is_implicated_in) | 7.63e-06 | 2 | 82 | 2 | DOID:1933 (is_implicated_in) | |
| Disease | Rubinstein-Taybi Syndrome | 7.63e-06 | 2 | 82 | 2 | C0035934 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.78e-05 | 195 | 82 | 6 | DOID:1574 (implicated_via_orthology) | |
| Disease | congenital heart disease (implicated_via_orthology) | 4.17e-05 | 69 | 82 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | 5.37e-05 | 616 | 82 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.37e-05 | 616 | 82 | 9 | C0376358 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.73e-05 | 152 | 82 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 7.59e-05 | 5 | 82 | 2 | C3281201 | |
| Disease | neutrophil count | TRAFD1 ATXN2 SMIM29 RC3H1 FURIN OSBPL1A NCOA1 CHD7 ZMIZ1 R3HDM1 ARID1A CREBBP JMJD1C | 1.08e-04 | 1382 | 82 | 13 | EFO_0004833 |
| Disease | Breast Carcinoma | 1.27e-04 | 538 | 82 | 8 | C0678222 | |
| Disease | Squamous cell carcinoma of esophagus | 1.46e-04 | 95 | 82 | 4 | C0279626 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.59e-04 | 7 | 82 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | sodium measurement | 1.99e-04 | 103 | 82 | 4 | EFO_0009282 | |
| Disease | Carcinoma, Transitional Cell | 2.04e-04 | 41 | 82 | 3 | C0007138 | |
| Disease | coffee consumption measurement, tea consumption measurement | 2.52e-04 | 44 | 82 | 3 | EFO_0006781, EFO_0010091 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 2.70e-04 | 45 | 82 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 2.70e-04 | 45 | 82 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 2.71e-04 | 9 | 82 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Adenocarcinoma of lung (disorder) | 2.79e-04 | 206 | 82 | 5 | C0152013 | |
| Disease | Carcinoma, Granular Cell | 3.13e-04 | 116 | 82 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.13e-04 | 116 | 82 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.13e-04 | 116 | 82 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.13e-04 | 116 | 82 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.13e-04 | 116 | 82 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.13e-04 | 116 | 82 | 4 | C0001418 | |
| Disease | neuroblastoma (is_implicated_in) | 3.38e-04 | 10 | 82 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Parkinson disease, late-onset | 3.38e-04 | 10 | 82 | 2 | cv:C3160718 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 3.38e-04 | 10 | 82 | 2 | 168600 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 4.13e-04 | 11 | 82 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 4.63e-04 | 54 | 82 | 3 | C0149925 | |
| Disease | PARKINSON DISEASE, LATE-ONSET | 4.94e-04 | 12 | 82 | 2 | C3160718 | |
| Disease | Coffin-Siris syndrome | 5.83e-04 | 13 | 82 | 2 | C0265338 | |
| Disease | Malignant neoplasm of skin | 6.01e-04 | 59 | 82 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 6.01e-04 | 59 | 82 | 3 | C0037286 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 6.20e-04 | 139 | 82 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 6.37e-04 | 140 | 82 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 6.55e-04 | 141 | 82 | 4 | C0005684 | |
| Disease | C-X-C motif chemokine 11 measurement | 6.79e-04 | 14 | 82 | 2 | EFO_0008057 | |
| Disease | taste liking measurement | 7.51e-04 | 388 | 82 | 6 | EFO_0010155 | |
| Disease | Malignant neoplasm of breast | NCOA2 ARID1B STARD8 AHR NCOA1 MAP7D2 ZMIZ1 ARID1A EP300 NOTCH1 | 7.79e-04 | 1074 | 82 | 10 | C0006142 |
| Disease | liver volume | 7.82e-04 | 15 | 82 | 2 | EFO_0600048 | |
| Disease | testosterone measurement | ARID1B TTBK1 AMER1 STARD8 NCOA1 CHD7 ZMIZ1 ARID1A LARP4 USH2A JMJD1C | 7.89e-04 | 1275 | 82 | 11 | EFO_0004908 |
| Disease | sclerosing cholangitis | 8.34e-04 | 66 | 82 | 3 | EFO_0004268 | |
| Disease | birth weight | 8.68e-04 | 399 | 82 | 6 | EFO_0004344 | |
| Disease | T-Cell Lymphoma | 8.93e-04 | 16 | 82 | 2 | C0079772 | |
| Disease | preeclampsia, hypertension, pregnancy-induced | 8.93e-04 | 16 | 82 | 2 | EFO_0000668, MONDO_0024664 | |
| Disease | Colorectal Neoplasms | 1.06e-03 | 277 | 82 | 5 | C0009404 | |
| Disease | glomerulonephritis (is_marker_for) | 1.27e-03 | 19 | 82 | 2 | DOID:2921 (is_marker_for) | |
| Disease | bilirubin measurement | 1.47e-03 | 442 | 82 | 6 | EFO_0004570 | |
| Disease | Cardiomegaly | 1.56e-03 | 82 | 82 | 3 | C0018800 | |
| Disease | Cardiac Hypertrophy | 1.56e-03 | 82 | 82 | 3 | C1383860 | |
| Disease | basophil percentage of granulocytes | 1.62e-03 | 83 | 82 | 3 | EFO_0007995 | |
| Disease | hypertension | 1.67e-03 | 307 | 82 | 5 | EFO_0000537 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 1.68e-03 | 84 | 82 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | Splenomegaly | 1.70e-03 | 22 | 82 | 2 | C0038002 | |
| Disease | Parkinson disease | 1.70e-03 | 22 | 82 | 2 | cv:C0030567 | |
| Disease | Renal glomerular disease | 1.86e-03 | 23 | 82 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.86e-03 | 23 | 82 | 2 | C4521256 | |
| Disease | alkaline phosphatase measurement | 2.02e-03 | 1015 | 82 | 9 | EFO_0004533 | |
| Disease | mean platelet volume | 2.08e-03 | 1020 | 82 | 9 | EFO_0004584 | |
| Disease | nevus count, cutaneous melanoma | 2.11e-03 | 91 | 82 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | Ischemic stroke | 2.12e-03 | 324 | 82 | 5 | HP_0002140 | |
| Disease | Left Ventricular Hypertrophy | 2.20e-03 | 25 | 82 | 2 | C0149721 | |
| Disease | Heart valve disease | 2.37e-03 | 26 | 82 | 2 | C0018824 | |
| Disease | lymphocyte count | NCOA2 OSBPL2 PCDHGB3 ATXN2 SMG9 CHD7 ZMIZ1 RRM1 JMJD1C PEBP4 PLCE1 | 2.38e-03 | 1464 | 82 | 11 | EFO_0004587 |
| Disease | apolipoprotein A 1 measurement | 2.47e-03 | 848 | 82 | 8 | EFO_0004614 | |
| Disease | Sezary Syndrome | 2.56e-03 | 27 | 82 | 2 | C0036920 | |
| Disease | immune system disease | 2.75e-03 | 28 | 82 | 2 | EFO_0000540 | |
| Disease | functional brain measurement, language measurement | 2.75e-03 | 28 | 82 | 2 | EFO_0007797, EFO_0007849 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| MQYNPVLPGQQAFLN | 786 | P35869 | |
| NPVQGAMYSFPRVQL | 406 | P24298 | |
| AFQLLGQTRANPMYN | 16 | P01160 | |
| GQTRANPMYNAVSNA | 21 | P01160 | |
| PVYMRQNINPGCQEQ | 116 | Q6XXX2 | |
| SNGQMGQPLRPQANY | 1256 | Q96RT1 | |
| YGPRMQQPSNQGQFL | 751 | Q09472 | |
| HGIRNGINPAMYQSP | 431 | P41595 | |
| QQPGEAYSAMPRAQP | 401 | Q4VCS5 | |
| RMNYMQNHQAGAPAP | 1961 | Q9HCK8 | |
| SNPNPIDPSSMQRAY | 471 | Q92793 | |
| GPCYNLQPQASQSMR | 1031 | Q5JTC6 | |
| TQRNPQMAQYGPQQT | 866 | Q8NFD5 | |
| NPSMNFPINYLQRAG | 1051 | Q9Y4B4 | |
| PYNPQQMGQQIFRSS | 511 | Q6P1W5 | |
| NNTPMNQSVPRYPNA | 336 | Q9P2D1 | |
| PAGNNMNRKNTPYQQ | 171 | P16562 | |
| PMAPVQYNAQRSQQM | 656 | Q9UBL0 | |
| YQVPMTQGSQGLPQQ | 726 | Q9UBL0 | |
| SYQQPIMLPNQAGQG | 741 | Q9UBL0 | |
| NDYVPSPTRNMAPSQ | 211 | Q9NYB9 | |
| YRQGQAAPPTAAMQQ | 41 | P43699 | |
| SQGIPHQTYQQPVMF | 741 | Q15032 | |
| MVPRGSQLYPAQQTD | 576 | Q5TC82 | |
| APELNPNGNATYVMT | 101 | Q9Y5P3 | |
| VRQMNYAAQPNGDEG | 161 | P61225 | |
| AEPNYMGSRQQFVQS | 861 | O14917 | |
| NDNRPMILYPLQNGT | 556 | Q9Y5F3 | |
| MHVAANSIQNRPPGY | 901 | O14497 | |
| LSRLQSGMVPNQYNP | 2311 | P46531 | |
| SGMVPNQYNPLRGSV | 2316 | P46531 | |
| GAVRTSQPNYRPQGM | 31 | Q96T17 | |
| VNQAKTYRAVPNMPQ | 991 | Q99700 | |
| TYRAVPNMPQQRQDQ | 996 | Q99700 | |
| NQYRMRGLNPGTVNS | 356 | P09529 | |
| QANSPRPAMNSQAAV | 281 | Q15652 | |
| MTQNYQDSPTLQAPR | 196 | Q96S96 | |
| VQSMALPPGVVNSYN | 261 | P58012 | |
| APSQGIPRVNYMQQL | 1211 | P10070 | |
| YMQQLRQPVAGSQCP | 1221 | P10070 | |
| MAAGVLPQNEQPYST | 1 | A2A3K4 | |
| NDNPPVFTQDMYRVN | 236 | Q9Y5G1 | |
| IAPRPPNSAQMYNFT | 836 | Q9BXW6 | |
| PMAQSYDQNPSPRAA | 696 | Q86Y26 | |
| AFQGPAAYQPDQMRS | 741 | Q8IV76 | |
| QQQLYGRSPSAVAMQ | 1871 | Q92794 | |
| PAIPGTNMYNTERAN | 1206 | Q9BYE9 | |
| QPYTGPMLNNQNTAV | 456 | Q6AI39 | |
| NDQDPDPQPRYTQMN | 176 | P09958 | |
| DPQPRYTQMNDNRHG | 181 | P09958 | |
| PQNRPNYNVSFSAMP | 746 | O75061 | |
| QTQAQYASPVFMQPV | 296 | Q71RC2 | |
| YVMQGNVDNQFPGQA | 161 | Q9BSE4 | |
| PINPSDINMIQGNYG | 81 | Q9BV79 | |
| NNAPGSPRYQLQMRS | 2461 | O75445 | |
| QSSNMQPPGYQSRHI | 151 | Q3ZLR7 | |
| PSRPINNMTATYNQL | 451 | O14545 | |
| SMQVQAYNGGNANPR | 1561 | Q9P212 | |
| LPNVNPDAGYAVQMS | 776 | O95486 | |
| TRNVMAYNVQQGFAP | 461 | Q8IZX4 | |
| QQNVFQYPGAGMVPQ | 1226 | Q15788 | |
| QPVAPYNTTQFLMND | 136 | Q96MH2 | |
| RPTQPVYQIQNRGMG | 141 | Q9H0W8 | |
| VPNAPQANSDSMVGY | 6 | Q86T20 | |
| QMQIAESSYPQPSQQ | 736 | Q9H0K1 | |
| SMNSNVSVYQPPRQV | 101 | P13598 | |
| INTRPPNSAQMYNFT | 366 | Q9H1P3 | |
| TGQPLPQSIQQAMRY | 581 | Q92502 | |
| QSSNMQPPGYQSRHI | 151 | P0C7V6 | |
| PSTTNLYLGNINPQM | 271 | O15042 | |
| NSQYQGMAAATPGQP | 101 | Q99966 | |
| PMAPYRPSQQGSSQQ | 231 | O75177 | |
| PVFPQQYASQAQMAQ | 1131 | Q15596 | |
| PMMQQSQANPAYQAP | 1336 | Q15596 | |
| QSYVIPPQAGQVQMS | 526 | Q9UN79 | |
| PLENAPIGHNRQYNM | 426 | P17643 | |
| PPQQNTRQTAAMFGV | 326 | Q5TCY1 | |
| PGSSYQQSPGEMQLN | 571 | P61129 | |
| GPSYQRAPQMPDSQR | 161 | Q9UMS6 | |
| NGNSNGLVPMLRVYN | 266 | P23921 | |
| MDQNNSLPPYAQGLA | 1 | P20226 | |
| APNSTNQMLYGLQSP | 436 | Q9Y458 | |
| NAAFQPNQYQMLAGP | 901 | Q9H0D6 | |
| LPSQQTQAAYPNTMV | 451 | Q92783 | |
| AGPNMPQVPNYNLTS | 501 | Q92783 | |
| RDMQPYMSQQNTGPL | 301 | P0C7H9 | |
| QYPPENLRVMVSQAN | 341 | Q96LC7 | |
| QNGSMLPNQPSGYRV | 366 | P31483 | |
| QAGSNGQPLPSQYMN | 1376 | O95405 | |
| QEGQTQRQPGSPMYR | 861 | Q9P275 | |
| GPTQAYNSQFMNQPG | 321 | Q9ULJ6 | |
| NPSYPVARAQPQTMF | 26 | Q8WZ26 | |
| NRSQPRAMGPENNLY | 76 | P20592 |